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ABSTRACT
SELFISH MUTATIONS:
THE GENETIC BASIS OF THE PATERNAL AGE EFFECT
Eoin C. Whelan
Old Dominion University, 2016
Director: Dr. Christopher Osgood

As the mean age of childrearing grows, the effect of parental age on genetic disease and
child health becomes ever more important. A number of autosomal dominant disorders show a
dramatic paternal age effect due to selfish mutations: substitutions that grant spermatogonial
stem cells (SSCs) a selective advantage in the testes of the father but have a deleterious effect in
offspring.
I present a mathematical model to analyse the normal function of the stem cell
compartment, which provides a framework for SSC renewal and accommodates differences
between animal systems. In order to model the SSC mutation accumulation, a Markov chain was
used to model the probabilities of mutation and positive selection with cell divisions. This model
provided average numbers of mutant sperm produced with increasing paternal age. The
proportions of mutant to wildtype cells with increasing paternal age was used to generate a
simulated population and observed/expected curves. These were then fitted against existing
disease and sequencing data. The parameter for the probability of positive selection per division
of a mutant cell was estimated. Incidence of the diseases was predicted closely for most disorders
and was influenced by the site-specific mutation rate caused by hypermutable CpG sites and the
number of mutable alleles. The incidence of disease was explained satisfactorily only when a
combination of positive selection and the site-specific mutation rate were included in the
analysis.
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To provide experimental evidence for the hyposthesis that paternal age effect mutations
present a selective advantage, I selected the mutation in the RET (REarranged during
Transfection) gene that causes multiple endocrine neoplasia type 2B. SSCs were created by
inducing differentiation to spermatogonia of induced pluripotent stem cells.

Wildtype and

mutant SSCs were generated by transfection with a plasmid containing the normal RET gene and
the gene containing the disease mutation, respectively. Mutant SSCs showed increased
proliferation in culture. This effect was counteracted when the mutant receptors were saturated
with their ligand, GDNF (glial-derived neurotropic factor).
This research demonstrated theoretical and experimental evidence for positive selection
in SSCs for multiple endocrine neoplasia type 2B and other paternal age effect syndromes.
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ABBREVIATIONS
Cell Types
MEF
iPSCs
SC
SSC
STO
TA cells

Mouse Embryonic Fibroblast
induced Pluripotent Stem Cell
Stem Cell
Spermatogonial Stem Cells
SIM (Sandos Inbred Mice) Thioguanine/Ouabain-resistant mouse fibroblast cell line,
used as a feeder layer.
Transit Amplifying cells

Diseases
ACH
FOP
MEN2B
TD

Achondroplasia
Fibrodysplasia Ossificans Progressiva
Multiple Endocrine Neoplasia Type 2B
Thanatophoric Dysplasia

Genes and Genetic Elements
CpG
Dinucleotide sequence of cytosine followed by guanine
DDX4
DEAD-box helicase 4, a marker for spermatogonia
FGFR
Fibroblast Growth Factor Receptor, the membrane receptor for FGF
FGF
Fibroblast Growth Factor, a growth factor
GDNF
Glial Derived Neurotropic Factor, a growth factor
PLZF
Promyelocytic leukaemia zinc finger protein, a marker for spermatogonia
RET
REarranged during Transfection, the membrane receptor for GDNF
Model Variables
α
Male-to-female mutation rate ratio
α1/α2/α3
Probability of a stem cell undergoing symmetric division (2 SCs) / asymmetric
division / symmetric division (2 TAs)
Probability of a TA cell undergoing symmetric division (2 TAs) / asymmetric
β1/β2/β3
division / symmetric division (2 differentiated cells)
μ
Mutation rate, per nucleotide per generation
n
Niche size (cells)
p
Mutation probability, per nucleotide, per cell division
q
Probability no mutation occurs, per nucleotide, per cell division (1 – p)
r
Probability of positive selection (i.e. symmetric renewing division)
pi
Probability of the niche gaining one net mutant cell after a cell division
Probability that the niche gains no net mutant cells after a cell division (1 – pi)
qi
M
Average number of mutant cells per niche
S
Simulated number of mutant births
O/E
Observed mutant births divided by the Expected mutant births
ν0/ν1
The rate at which SC divide (ν0) / TA cells divide (ν1)
γ0/γ1/γ2
The apoptosis rate of stem cells (γ0) / TA cells (γ1) / differentiated cells (γ2)
The size of the SC/TA/differentiated cell compartments
X0/X1/X2
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CHAPTER 1
INTRODUCTION TO THE PATERNAL AGE EFFECT

1.1 Paternal Age
As the average age of parenthood becomes more delayed, understanding the effect of
parental age on child health becomes more important. (Bray et al. 2006). The effect of maternal
age has long been acknowledged (Hook 1981) but in recent years the effect of paternal age has
been the subject of a great deal of study. An association between incidence of genetic disease
and increasing paternal age was first noted by Weinberg (1912) while studying risk factors for
achondroplasia. Advanced paternal age is now associated with a number of mutations that cause
dominant disorders and X-linked diseases (Vogel 1975, Risch et al. 1987, Glaser & Jabs 2004).
It has also been linked to degeneration of other polygenic traits in human offspring; reduction in
longevity (Gavrilov 1997), decrease of telomere length (Unryn et al. 2005), reduced IQ
(Malaspina et al. 2005), increased sporadic incidence of polygenic diseases such as
schizophrenia (Sipos et al. 2004, Malaspina et al. 2002), autism (Reichenberg et al. 2006) and
multiple sclerosis (Montgomery et al. 2004).

Congenital defects, cancer predisposition

disorders, bipolar disorder, and Alzheimer’s disease have also been linked to father’s age
(reviewed in Paul and Robaire 2013).

1.2 Copy-error
Due to the larger number of male germline cell divisions compared with the female germline,
males produce 3-6 times as many mutations than females throughout evolution (Li et al. 1996).
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Sperm are produced by a continually-dividing population of stem cells and each division
represents a chance for replication errors to happen. Haldane (1935, 1947) noted a male-bias in
the incidence of haemophilia A and suggested that this could be accounted for by fidelity errors
in replication. Penrose (1955) proposed that replication errors also provided an explanation for
the observed increased incidence of mutation with advanced paternal age. In many cases the
influence of paternal age is relatively subtle compared with the large scale chromosomal
abnormalities characteristic of maternal age effect because point mutations typically have small
or no effect on phenotype. However certain substitutions can have devastating effect on those
who carry the allele.

1.3 Positive Selection
Diseases that show a strong paternal age effect, however, are not explained purely by Penrose’s
copy-error hypothesis. These diseases show an exponential increase in incidence with father's
age. The mutations responsible typically display a very specific spectrum of mutations, often
caused by missense substitutions at very specific sites. Mutations accumulate faster than the raw
mutation rate can account for. Mutations in these disorders present in clumps, indicating a
positive selective mechanism of mutation accumulation as opposed to a high mutation rate or
“hot spot” model. Such evidence has so far presented for achondroplasia (Shinde et al. 2013),
Apert’s syndrome (Qin et al. 2007, Choi et al. 2008), Costello syndrome (Ginnoulatou et al.
2013) and Noonan Syndrome (Yoon et al. 2013). There is a parallel with the intestinal crypt
where mutant cells colonise their niche through selective advantage conferred by their new
phenotype (Bozic & Nowak 2013). It is also relevant to cancer etiology as paternal age effect
mutations are typically found in tumors (Maher et al. 2014).
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1.4 Outline
In this thesis I present multiple avenues of research into this phenomenon. First I
introduce a mathematical model of the stem cell niche. Chapter 3 is a mathematical and
computational analysis of the paternal age effect and premeiotic selection, comparing the model
to existing disease and mutation data. Finally I present in vitro analysis of one particular
mutation, the M918T mutation in the RET gene that produces the disease Multiple Endocrine
Neoplasia type 2B and show that spermatogonial stem cells carrying this mutation do indeed
show a selective advantage that would explain the exponential paternal age effect.
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CHAPTER 2
PATERNAL AGE AND THE MUTATION RATE
2.1 Paternal age and cell divisions.
In contrast to the human female germ cell line, which undergoes 22 divisions by birth
(after which oogenesis is complete and the oocytes persist until the final two meiotic divisions
[Vogel & Rathenberg 1975]), the gonocytes of the male germ cell line continue to divide after
birth. By puberty, the stem cells have divided ~30 times and continue to divide at an estimated
rate of one division every 16 days (de Rooij & Russel 2000, de Rooij & van Beek 2013)
although this is likely to decrease as the male ages (Vogel & Motulsky 1997). With no reduction
in cell division rate with age, a man’s germ cells will have divided 600 times by age 40 (Vogel &
Rathernberg 1975). This disparity of cell division number has a dramatic effect on the number
and types of mutation between the sexes and accumulate with age.

2.2 Types of mutation
Particular types of mutation are associated with paternal transmission, primarily point
mutations and other mitotic errors, due to the much greater number of cell divisions in the male
germ line (Miyata et al. 1987). According to this principle, continued cell division in the male
germ-cell line translate into a build up of replication-dependent mutations, thus the risk of
disease caused by these errors rises with age (Glaser & Jabs 2004). On the other hand, mutations
associated with maternal transmission, such as chromosomal aneuploidies or deletions, are not
expected to be associated with paternal age (Glaser & Jabs 2004). For any given syndrome one
would expect the strength of the paternal age effect to be governed by the type of mutation: those
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that are maternally-inherited or show no parent-of-origin effect may dilute or mask the
cumulative excess of replication-dependent mutations from the male germ line with age.

2.2.1 Point mutations
The majority of human syndromes that show the strongest paternal age effect are
autosomal dominant disorders characterised by point mutations (see Fig. 1 and Glaser & Jabs
2004). In two disorders nearly all instances of disease are caused by one transition at a single
position within the gene (achondroplasia [Bellus et al. 1995, Wilkin et al. 1998] and
fibrodysplasia ossificans progressive [Shore et al. 2006]), while others can be caused of a variety
of point mutations at different sites (e.g. Crouzon and Pfeiffer syndromes [Passos-Bueno et al.
1999]). Approximately half of human paternal age effect syndromes that are known to be caused
exclusively by point mutations occur in the context of CpG dinucleotides (i.e. cytosine and
guanine nucleotides present adjacent within the genome, see Table 1).
There are syndromes that do not appear to fit this pattern, however. Alexander disease
would seem to be a prime candidate for a paternal age effect: almost all mutations are simple
missense substitutions which display a pronounced paternal origin of mutation. Yet curiously,
while the average age for the parents of the proband (i.e. affected individual) is higher than the
average for the control population, this was not significant (P>0.5, T-test, Li et al. 2006).
The paternal-age effect is also apparent in X-linked diseases. A novel mutation may
appear to occur in the mother’s germ line, or the mutation may have originated in a previous
generation. Assuming most mutations occur in males, the most likely event is that the mutation
arose on an X chromosome produced by the maternal grandfather (due to the greater number of
cell divisions in his embryonic stem cell line compared with the germ lines of the grandmother or
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mother) and that the proband’s mother would be a carrier. Becker et al. (1996) found a
significant grandpaternal age effect apparent in individuals with haemophilia A, when only those
cases that originated from de novo point mutations were considered. When all types of mutation
were analysed together (including deletions acquired from the mother), there was no significant
effect of grandpaternal age, consistent with the theory that maternally-derived mutations conceal
the paternal age effect. A grandpaternal age effect has also been suggested in regard to LeschNyhan disease (Franke 1976).

Syndrome

CpG

CpG transition/
transversion

Reference

Achondroplasia

Yes

Transition

Bellus et al. 1995,
Wilkin et al. 1998

Apert

Yes

Transversion

Costello

Yes

Transition

Crouzon

No

Fibrodysplasia ossificans
progressiva

Yes

Transition

Muenke-type craniosynostosis

Yes

Transversion

Multiple endocrine neoplasia 2A

No

Multiple endocrine neoplasia 2B

No

Noonan

No

Pfeiffer

No

Progeria

Yes

Transition

Eriksson et al. 2003,
Cao & Hegele 2003

Thanatophoric dysplasia

Yes

Transition

Tavormina et al. 1995

Shore et al. 2006

Table 1 - Syndromes with paternal age effect caused by point mutations.
For those syndromes (n=7) where the majority of point mutations are at CpG dinucleotides, the
type of substitution (transition/ transversion) is noted. Data from (Online Mendelian Inheritance
in Man, 2016) except where noted.
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Fig. 1 - Paternal and maternal ages for human syndromes demonstrating a paternal age effect.
Average age for the parents of an affected child is shown (mutant) with the average maternal and paternal
ages of the control population census (control). Diseases shown in bold have been shown to have an
exponential paternal age effects (Risch et al. 1987, Glaser & Jabs 2004) and have been ordered by
decending ratio of male:female parental age. Data adapted from Glaser & Jabs (2004), with additions
from: (a) Lurie 1994, control data from the 1990 census of Japan, Department of Statistics, Ministry of
Internal Affairs and Communications, Japan (note that due to the variety of patients in Lurie 1994, control
data is intended for comparative basis only) (b) Orioli et al 1995 (combined IPIMC and ECLAMC data),
(c) Rannan-Eliya et al 2004, (d) Tartaglia et al (2004) (e) Orioli et al 1995 (combined IPIMC and
ECLAMC data). (c) and (e) did not attain formal statistical significance in the samples cited, but showed
strong paternal age effect trends (p=0.06 for both Muenke-type craniosynostosis and the ECLAMC cohort
of osteogenesis imperfecta, Rannan-Eliya et al 2004, Orioli et al 1995).
BR=bilateral retinoblastoma; T-CS=Treacher Collins syndrome; AP=achondroplasia; AD=acrodsostosis;
ME=multiple exostoses; ODD=oculodentodigital dysplasia; BCN=basal cell nevus; MTC=Muenke-type
craniosynostosis; MEN2A=multiple endocrine neoplasia type 2A; WS=Waardenburg syndrome; OI=osteogenesis
imperfecta; CD=cleidocranial dysostosis; NF=neurofibromatosis.
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2.2.2 Insertions/deletions
Deletions are not associated with parent-of-origin effects since these occur most
commonly during meiosis (Glaser & Jabs 2004). While some of the paternal age effect
syndromes in Fig. 1 are associated with a range of mutational types (including insertions,
deletions and rearrangements as well as point mutations), but these are for the most part,
syndromes designated by Risch et al. (1987) to be only weakly associated with paternal age.
Thus a weak association indicates that a variety of mutational processes are at work and that ageindependent insertions/deletions are mitigating or masking the paternal age effect caused by
replicative mutations.

2.2.3 Tandem repeats

Tandem repeat mutations are postulated to be associated primarily with replication
slippage (Ellegran 2000) and as such can be expected to show a paternal age effect.
Huntingdon’s disease, caused by an expanded (CAG)n repeat, shows a pronounced paternal age
effect in the probability of repeat expansion, and children of older fathers with the premutation
allele are more likely to inherit increased number of triplet repeats with a greater change in
repeat number. Huntingdon’s disease shows a paternal age effect regardless of which parent
passes on the mutant allele, indicating that genomic imprinting is involved in repeat expansion
(Evans-Galea et al. 2013, Farrer et al. 1992). Similarly, fragile X syndrome (an X-linked
disorder associated with permutation transmission of [CGG]n triplet repeats in the FMR1 gene)
demonstrates a correlation of increasing paternal age with a greater magnitude in repeat number
change: older fathers are more likely to pass on a mutated allele involving a large expansion than
younger fathers (Ashley-Koch et al. 1998). Human microsatellites, in general, demonstrates a
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paternal age effect (Nikitina & Nazarenkon 2004), wherein a male bias of 17:3 is seen in the
frequency of mutational events (Brinkmann et al. 1998).

2.2.4 Chromosomal abnormalities:
Historically, an association of advanced male age with chromosomal aneuploides has
been postulated (Rives et al. 2002, Sartorelli et al. 2001), but more recent data suggests that there
is little or no association between older paternal age and chromosomal aneuploidies (Fonseka &
Griffin, 2011, Jung et al. 2003), with the exception of disomic sex-chromosome incidence
(Kühnert & Nieschlag 2004) such as the frequency of XY sperm causing Klinefelter’s syndrome
(Lowe et al. 2001).

Column A
Autosomal
dominant disease
with strong
paternal age effect
Achondroplasia
Apert
Crouzon & Pfeiffer
MEN2A
MEN2B
Muenkea
Noonanb

Weighted mean

Column B
α

n

X-linked disease

∞
∞
∞
∞
∞
∞
∞

40
57
22
10
25
10
14

Column C
α

n

Haemophilia Ac
Haemophilia Bd
Pelizaeus-Merzbacher
Rett

9.4
8.6
4
13.5

44
42
5
29

Other autosomal diseases
NF2
Von Hippel-Lindau disease
FAPe
Alexander diseasef
Townes-Brocksg

1.3
1.3
3.0
6
7

23
7
16
28
16

Total

Total

178

210

∞

7.4

Higher primate
comparative studies
Huang et al. 1997
Shimmin et al. 1993
Chang et al. 1996
Makova & Li 2002
Ebersberger 2002
Anagnostopoulos 1999
Bohossian et al 2000
Erlandsoon et al 2000
Agulnik et al 1997

α
5.14
6.26
4.2
5.25
3
3.5
1.7
2.5
4

4.0

Table 2 - Human male/female mutation ratio estimates.

Data from Li et al. 2002 unless noted otherwise. (a) Rannan-Eliya et al. 2004. (b) Tartaglia et al.
2004 (PTPN11 cohort only). (c) Becker et al. 1996 (α value listed is the mean of those derived
from direct and indirect estimates). (d) Green et al. 1999. (e) Shore et al. 2006. (f) Li et al. 2006.
(g) Böhm et al. 2006.
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2.3 Male-to-female mutation rate
The ratio of male-to-female mutation rates (α) has been estimated in humans through two
methods. Evolutionary biologists have analyzed molecular sequence variation between closelyrelated species and measured sequence divergence between sex chromosomes and autosomes.
While autosomes are equally divided between the sexes, at any given time two thirds of the Xchromosomes will be found in females and Y-chromosomes are only found in males. The
substitution rate (μ) can be inferred from sequence divergence of homologous chromosomes
between taxa. Assuming the female mutation rate to be proportional to 1, then the mutation rate
of the Y-chromosome will be α, and the X-chromosome mutation rate will be (α+2)/3, as these
are found with a frequency of 2/3 in females. Thus the sex differential in mutation rate within
taxa can be calculated from the ratio of substitution rates between the sex chromosomes:
μY/μX=3α/(2+α) (Miyata et al. 1987). The second method has been used by medical researchers
looking at parental origin of de novo autosomal dominant and X-linked recessive disorders (α =
μm/μf). A summary of data derived by both methods is shown in Table 2. Column A shows those
autosomal dominant disorders associated with an exponential increase in paternal age for which
parent-of-origin data is known. This subset of the data shows an exclusively paternal origin of
mutation. For those disorders that are not associated with a strong paternal age effect, column B,
the male:female ratio average does not differ significantly from that calculated via sequence
analysis for primates over evolutionary time, column C (p>0.10 paired T-test). Both results
correspond to the average difference in germ line division between the sexes. Assuming a
generous male-to-female mutation ratio (α=15), the probability that of all the mutations listed in
Column A (n=178) not one originated in the maternal germ line can be calculated as p = (α1/α)^n = (14/15)^178 = 0.000005. Clearly there is an underlying mechanism that has skewed the
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parent-of-origin effects of those disorders characterised by a strong paternal age effect far
beyond the normal male-to-female ratio.

2.4 Patterns within the data
While mutations associated with the paternal age effect broadly fall within the classical
spectrum of replication errors (Glaser & Jabs 2004) there are a number of anomalies that are not
explained by the simple copy-error hypothesis. (a) The male-to-female mutation rate in these
syndromes, particularly those strongly associated with paternal age, appears to be highly skewed
toward paternal origin of disease alleles (see Table 2), far more than would be expected from the
difference in germ cell divisions. (b) There are a number of genetic diseases which are
predominantly caused by point mutations that do not show any paternal age effect – for example,
Alexander’s disease (OMIM: 203450, Li et al. 2006) and Townes-Brocks syndrome (OMIM:
107480, Böhm et al. 2006). (c) Over half of the strongly age-associated syndromes are caused by
mutations at CpG dinucleotides, which are not commonly understood to be replication mediated
(Table 1). (d) Risch et al. (1987) found an exponential increase in incidence of disease that is
positively associated with paternal age for the majority of disorders (those designated as having a
strong effect in Fig. 1). This casts doubt on the copy-error hypothesis, since, if single-gene
mutations were accruing solely due to cell division one would expect a linear increase with age
(Risch et al. 1987). The exponential effect may instead be explained by differential methylation,
degradation of repair enzymes, replication fidelity senescence or positive selection.
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Fig. 2 - Spontaneous deamination of 5-methylcytosine to thymine.
Hydrophilic attack at C-4 of 5-methylcytosine substitutes a hydroxyl group for the amino group,
which via tautomeric shift becomes a double-bonded oxygen and forms thymine (Walsh & Xu,
2006, Cooper & Krawczak 1993, Vogel & Motulsky 1997)

2.5 Methylation effects
CG couplet sequences form mutational ‘hotspots’ in mammals. Cytosines within CpG
dinucleotide sites are usually subject to methylation and the increased substitution rate is due to
the fact that 5-methylcytosine can spontaneously deaminate to form thymine (see Fig. 2), which
is commonly thought to be replication-independent. Transitions at CpG dinucleotides are
reported to be the most common type of point mutation in humans (Antonarakis 2000),
constituting approximately 23% of human coding gene mutations (Krawczak et al. 1998,
Krawczak & Cooper 1997). As a consequence, CpG sites are rare throughout mammalian
genomes in comparison to the expected number assuming a random distribution. (Subramanian
& Kumar 2003). While cytosine is prone to deamination to uracil, this change is quickly and
efficiently corrected by repair enzymes such as uracil DNA glycosylase since uracil is not
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normally found in DNA (Walsh & Xu 2006). Deamination of 5-methylcytosine is much harder
for mismatch repair enzymes to recognise since thymine is a normal component of DNA. When
this occurs, it leaves a T=G mispair. If not corrected by mismatch repair enzymes, this mistake
will be incorporated as a point mutation in one of the daughter strands when the cell divides (Fig.
3).
Transitions at CpG sites are the cause of many human diseases, including several
dominant disorders with pronounced paternal age effect and paternal origin of mutation (see
Table 1). This is surprising because if transitions at CpG dinucleotides are purely timedependent, there should be no difference in mutation rate between the sexes.
There is some evidence that deamination is enhanced by replication. The mismatch-repair
enzymes which function to remove the thymine from the T=G mispair – such as methyl-CpGbinding proteins or thymine DNA glycosylase – are much less efficient than the corresponding
uracil-excision enzymes (Pfeifer 2006, Lindhal 1993). One can hypothesise that if deamination
of 5-methylcytosine occurs randomly, one would expect more fixation of mutation in dividing
cells: if the DNA replication process occurs before the mismatch-repair process, the mutation
will be fixed in one of the daughter cells (see Fig. 3). In non-dividing cells, however, the
mismatch repair enzymes have almost unlimited time to repair the mismatch. Methylated CpG
sites in non-dividing E. coli cells have been described as stable and not mutational hotspots,
consistent with this hypothesis (Lieb and Rehmat 1997).
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Fig. 3 - Deamination mutation and repair.
(a) Methylated CpG dinucleotide. Spontaneous deamination (Vogel & Motulsky 1997) or action
via deaminase enzymatic activity (Morgan et al. 2004) leads to a T=G mismatch (b). Mismatch
repair enzymes such as thymine DNA glycosylase (Walsh & Xu 2006) or methyl-CpG-binding
proteins (Brero et al. 2006) excise the out-of-sequence thymine and replace with an
unmethylated cytosine (c). Methylation is restored via DNA methyltransferase (a) (Bird 1999). If
repair of the T=G mismatch (b) does not occur before the next DNA replication event, the
thymine base will be incorporated in one of the daughter strands as a new point mutation (d)
(Lindahl 1993).
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CpG dinucleotides may be particularly vulnerable to the deamination of 5-methylcytosine during the de novo methylation process itself. DNA methyltransferase binds to the C6
position of the cytosine ring, forming a dihydropyrimidine intermediate that is prone to
deamination (Lindahl 1993), and dividing cells will have to remethylate half their genomes with
each replication. Replication might also enhance mutation as the DNA is in a single-stranded
form for longer, which is more vulnerable to deamination (Impellizzeri 1991).
DNA deaminases are expressed in germ cells, possibly for epigenetic reprogramming,
and could pose risk as a mutagen if mistargetted (Morgan et al. 2004), although these may
normally be active only in non-dividing stages of the cell cycle, as a preventative measure.
Furthermore, it has been suggested that deaminases are catalysts of demethylation. Deaminases
work by causing a transitional mutation of the 5-methylcytosine, which, after repair of the
mismatch, leaves the cytosine unmethylated (see Fig. 3). Failure to repair such deamination
would be a source of mutation, particularly in times of extensive demethylation, such as the
paternal genome undergoes, shortly after fertilisation. In this case it would be most likely to
cause mosaicism of mutation as the zygote consists of multiple cells.
The relative male to female mutation rates (α) can be estimated by relative comparison of
chromosome mutation rates derived from sequence homology alignments of closely-related
species. Anagnostopoulos et al. (1999) found many more CpG transitions on the Y-chromosome
relative to the X-chromosome. However, Nachman & Crowell (2000) and Smith & Hurst (1999)
found no significant difference in the number of transitions between autosomes and the Xchromosome, which would be predicted if transitions were replication-dependent. Taylor et al.
(2005) found that in human-chimp comparisons, CpGs sites demonstrate weak male mutation
bias, far lower than would be expected if transitions were purely replication-dependent. This is
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consistent with the molecular data indicating that transitions at CpG dinucleotides should not be
considered totally replication-independent, but are chiefly random events that occur only
moderately more in mammalian males than females, unlike other point mutations.
Differential methylation of maternal and paternal chromosomes would also contribute to
the skew in mutational origins. As female imprinting patterns are established in the oocyte prior
to fertilisation and male imprints are established at birth and persist throughout life, differential
methylation of gonocytes could contribute to the paternal age effect (Schaefer et al. 2007).
However, the paternal germ line has more hypomethylated regions than somatic tissue does
(Biermann & Steger 2007), and paternally imprinted genes are usually controlled by other
regulatory elements such as noncoding RNAs. This dimorphism may be due to selective
pressures to reduce deamination mutations within the male germ line (Bourc’his & Bestor 2006).
Although data is scant for most syndromes, El-Maarri et al. (1998) showed equal methylation in
both maternal and paternal germ lines for the Factor VIII and FGFR3 genes, indicating that
discrepancy in methylation is not a factor in the incidence of diseases associated with these
genes.

2.6 Germ-line replication fidelity with age
The paternal age effect has been observed in mice, which demonstrate a linear increase in
mutation frequency with age (Walter et al. 2004, 1998, Ono et al. 2000). Only the mutation rate
within the germ-line is of relevance to disease in the progeny, and the mutation rate in the germline is consistently lower than other tissue types (Ono et al. 2000, Hill et al. 2004, Nishino et al.
1996), and base excision repair genes show the highest levels of expression in the testes (Intano
et al. 2001). Decreased expression of base excision repair genes has been described as associated

17
with both age and mutational frequency in older mice (Huamani et al. 2004); however other
studies have found DNA repair to remain relatively well conserved with age (Intano et al. 2001)
with little change evident in the male germline mutation rate with age (Hill et al. 2004, Nishino
et al. 2004). A decrease in germ-line replication fidelity also doesn’t explain the large
heterogeneity in paternal age effect between syndromes with paternal origin of mutation. There
is little evidence for a dramatic decrease in germ line repair system efficiency being responsible
for the dramatic increase in mutation rate with age.

2.7 Protein-driven positive selection
One mechanism that could explain the observed increase of disease with paternal age is
selective advantage of mutant cells, either through premeiotic clonal expansion within the germ
line or via selective advantage for sperm. Gain-of-function advantage to sperm was first
proposed as an explanation for the high incidence of the G-to-A transition of FGFR3 within a
CpG dinucleotide at base pair 1138 in achondroplasia (Tiemann-Boege 2002, Hurst & Ellegren
2002). Empirical evidence for protein-driven positive selection was found in an analysis of
FGFR2 mutations which cause Apert’s syndrome. Goriely et al. (2005, 2003) found that the C
→ G transversion mutation at the mutant CpG dinucleotide is more common than the transition
C → T, despite transitions being generally more common, suggesting a greater selective
advantage for the transversion, which is corroborated as the variance of this mutation is greater.
Neighbouring nucleotide mutation rate was not elevated, nor was the C → T mutation at the
same site (which produces a stop codon). Goriely and colleagues found several examples of
double mutants, which would be very improbable without some form of selection operating.
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Fig. 4 - Signalling pathways which involve paternal age effect mutations.
Pathways adapted from KEGG pathways resource (http://www.genome.jp/kegg/, Kanehisa et al
2006) with additional references below. Groups of proteins belonging to major signaling
pathways are highlighted above: (A) JAK-STAT pathway; (B) MAPK pathway; (C) Wnt
pathway; (D) TGF-β pathway; (E) Hedgehog pathway.
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
11)
12)
13)
14)

Hilton et al. 2005, Bernfield 1999
Pradervand et al 2004
Takahashi 2001
Wellbrock & Marais 2005, Wellbrock & Arozarena 2016,
Tachibana et al. 2000
Mograbi et al. 2003
Franceschi et al. 2003
Moro et al. 2005
Tharaux et al. 2000
Dorner et al. 2006, Varela et al. 2005
Byers 2004, Pradervand et al 2004
Bakin et al. 2003
Melcon el al. 2006
Yang et al. 2002
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Screening for the same mutations in blood showed no elevated mutation rate for any of the
mutations and the C → G mutation rate did not show the abnormal elevation for a CpG site
(Goriely et al. 2005, 2003). The results of an increase in sperm mutation frequency with age for
achondroplasia has been replicated, but only one of two cohorts displayed an age-enhanced rate
for Apert’s syndrome substitutions (Wyrobek et al. 2006).

2.7.1 Positive selection and strong paternal age effect syndromes
Fig. 4 shows a representation of the signalling pathway network involving gene products
mutated in disorders associated with paternal age effect syndromes. Most of the proteins fall
within pathways that are canonical requirements of cancerous cells evolving constitutive growth
and resistance to antigrowth signals (Kelleher et al. 2006, Hanahan & Weinberg 2000). It is
therefore unlikely to be a coincidence that advanced paternal age has been associated with
increased risk of cancer in progeny (Paul & Robaire 2013, Yip et al. 2006, Choi et al. 2005).
Indeed, almost all of the genes which cause disease associated with paternal age are also known
to contribute to cancer in somatic tissue (see Table 3).
This raises the possibility that the gross increase of incidence with paternal age of all stronglydesignated syndromes – especially those that show mutations at CpG couplets, encode receptors
or regulatory proteins such as transcription factors (which may be gain-of-function mutations) or
are involved with cell division regulation (oncogenes/tumour suppressors) – is due to the
selective advantages of these mutations rather than specific mutability of the genes in question.
Since positive selection has been found to be a factor in Apert’s syndrome incidence, it
may potentially play a role in other FGFR2 diseases such as Crouzon and Pfeiffer syndromes.
Basal cell nevus mutations affect the sonic hedgehog protein which, amongst other things,
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governs stem cell division (Katoh & Katoh 2006). In fibrodysplasia ossificans progressiva, a
single mutational hotspot occurs within a CpG dinucleotide in the ACVR1 gene and it encodes a
BMP receptor in the TGF-β signalling pathway. Taken together this is suggestive of positive
selection. Multiple endocrine neoplasia 2B shows a mutational hotspot (creating a CpG site) at
codon 918 affecting the catalytic core of the tyrosine kinase domain of RET (Carlson et al. 1994)
and positive selection for RET mutations has been demonstrated in cancerous cells (Babenko et
al. 2006). Hutchinson-Gilford’s progeria is predominantly caused by a transition at a single CpG
site, affecting the regulatory lamin A protein. This disrupts the Rb1 cell cycle control via
interaction with the LAP2α protein (Dorner et al. 2006), but mutations in LMNA can also affect
structural nature of the nuclear envelope which in turn results in accumulation of DNA damage
and activation of the p53 signalling pathway (Cadiñanos et al. 2005). Fibrillin is a structural
protein forming the lattice that traps TGF-β and, when mutated, induces overstimulation of the
pathway leading to cell proliferation (Chaudhry et al. 2007). Finally, PTPN11, the mutant gene
frequently responsible for Noonan’s syndrome, is a phosphatase that is important to cell division
and cell survival through simulation of the MAPK pathway (Gelb & Tartaglia 2006).

2.7.2 Positive selection and weak paternal age effect
Those disorders characterised with a linear rather than exponential incidence increase
with age are hypothesised to show a weaker effect due to the masking effect of maternallyderived mutations (Glaser & Jabs 2004). The relatively weak effect of these syndromes can be
contrasted in many cases with that of other syndromes with predominant paternal origin of
mutation yet which show little or no measurable paternal age effect at all (e.g. haemophilia A
[Becker 1996] and Alexander disease [Li et al. 2006]).
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The retinoblastoma and neurofibromatosis proteins are inhibitors of cell proliferation, and
mutations are usually passed on from the paternal side (Glaser & Jabs 2004, Dryja et al. 1989,
Jadayel et al. 1990), although deletions are common. The mutant genes responsible for multiple
extostoses (EXT1-3) are involved in the synthesis of heparan sulphate, which is important for the
correct functioning of many cell-surface receptors including fibroblast growth factor receptors,
TGF-β pathway receptors and PTCH (Hilton et al. 2005, Bernfield 1999). Lastly, NSD1, the
gene product mutated in Sotos syndrome, is a regulator of androgen, the testosterone receptor:
the male-specific hormone which is critically involved in spermatogenesis and preventing germcell apoptosis (Dohle et al. 2003). It is also a key factor in prostrate cancer (Yang et al. 2002).

2.8 Conclusions
Many of the human genetic diseases with a paternal age association display an effect that
increases faster than would be expected by the copy error hypothesis alone (Goriely & Wilkie
2012, Risch et al. 1987). Over half of the most dramatic paternal age effects occur in syndromes
where the majority of mutations are transitions at CpG dinucleotides (Table 1), which are
associated with being time-dependent and would not be expected to show a paternal excess, let
alone the extreme mutational hotspots and association with paternal age that these syndromes
display. The diseases which show a strong increase in incidence with paternal age are also
associated with an exclusively paternal origin of mutation (see Table 2)
While spontaneous deamination of 5-methylcytosine should not be considered totally
replication-independent, there is little evidence of a drastic replication-connected mechanism that
would account for the exponential increase in mutations seen with paternal age, or the large
variance in the paternal age effect within disorders that are caused primarily by point mutations.
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Equally there is little evidence that differential methylation between male and female germ cells
is causing this severe age effect. The germ-line repair enzymes are relatively protected from
senescence and while accumulation of both methylated-related and replication-mediated
mutations due to deficiency in repair undoubtedly occurs, again it is not a convincing candidate
for explaining the paternal age effect. The large variance in influence of paternal age on differing
syndromes with similar mutational origins strongly suggests that a general mechanism such as
breakdown in repair enzymes or mutational clusters is not the cause: this would be expected to
have a broadly similar effect on different point mutations.
Protein-driven positive selection of mutant germ cells has been evaluated for Apert’s
syndrome (Yoon et al. 2009, Goriely et al. 2005). There is a striking pattern within the set of
paternal age effect syndromes of mutated gene-products being involved with cell cycle and
proliferation (Table 3 and Fig. 4). This suggests that mutations in the germ line causes
premeiotic expansion of the affected stem cell, causing the observed exponential increase in
mutation frequency with age, especially since direct measurement of mutation in germ line cells
in mice show a linear increase (Ono et al. 2000). The weakly-associated syndromes may show
less pronounced paternal age effects due to one or more of the following: a) stronger selection
masked by concealing effects such as maternally-derived cytogenetic mutations, b) weaker
selection, or c) true copy-error mutational accumulation. Given their importance in cell cycle
control pathways, bilateral retinoblastoma and neurofibromatosis may be more easily explained
as a case of large deletions which do not show a paternal age effect masking a stronger positive
selection effect (deletions in NF1, for example, are usually maternally-derived, while pointmutations are from the father’s side). Weak effects, such as those seen in haemophilia A and
Treacher-Collins syndrome, are probably due to real copy-error effects. Haemophilia A in
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particular shows a paternal age effect specific to point mutations, consistent with the copy-error
hypothesis.
The hypothesis that positive selection is the primary factor in the paternal age effect also
provides an explanation for syndromes with a marked paternal origin of mutation, but no
observed effect of father’s age, such as Alexander disease (Li et al. 2006) and Townes-Brocks
syndrome (Böhm et al. 2006). Without exacerbation of the paternal age effect, any increase in
male mutation rate due to the copy error mutation accumulation might be too weak to measure
significantly, especially using the limited sample sizes characteristic of human disease. In the
case of haemophilia A, the paternal origin of mutation has been observed, but a paternal age
effect is so weak it is only observable when deletions are excluded from the analysis (Becker et
al. 1996).
In future study of the paternal age effect, tests for protein-driven positive selection can be
conducted, as this appears to be the major contributing factor. For those researchers attempting to
calculate male-to-female mutation ratios, those estimates of α derived from human genetic
disease that display a paternal age effect are likely heavily skewed by positive selection.
Predictions based on the hypothesis that the strong association of certain mutations with paternal
age is due to positive selection can be made, for example, changes to the SOS (son of sevenless)
gene has been characterised within hereditary gingival fibromatosis and a form of Noonan’s
syndrome, both inherited primarily as autosomal dominant disorders. The key positioning of
SOS within the MAPK cascade, and the fact that it mediates signals between other proteins
mutant in strong paternal age effect syndromes – such as the FGF receptors, SHP2 and RAS –
makes the possibility that certain mutations associated with this gene could provoke a strong
positive selective effect on mutation rates tantalizing, but as yet this has not been studied.

OMIM

Mutant Gene

Protein function

Acrodysotosis

101800

(unknown)

Achondroplasia

100800

FGFR3

Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.

Apert’s syndrome

101200

FGFR2

Basal cell nevus

109400

PTCH

Cleidocranial dysostosis

119600

CBFA1

Crouzon syndrome

123500

FGFR2

FOP

135100

ACVR1

Marfan syndrome

154700

FBN1

MEN2A

171400

RET

MEN2B

162300

RET

Noonan’s syndrome

163950

PTPN11/SHP2

Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.
Sonic Hedgehog receptor – key role in essential developmental processes including
regulating stem cell division.
A transcription factor of the runt domain gene family – regulates osteoblast and chondrocyte
differentiation & migration.
Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.
BMP receptor - important roles during osteogenesis, chrondogenesis, neurogenesis &
haematopoiesis
Constituent of microfilbrils in extracellular matrix.
Receptor tyrosine kinases – interior cell-surface, transduce signals for cell growth and
differentiation.
Receptor tyrosine kinases – interior cell-surface, transduce signals for cell growth and
differentiation.
Nonreceptor protein tyrosine phosphatase – important for signal response and cell division.

Oculodentodigital dysplasia

164200

Cx-43

Connexin– transmembrane gap junction protein, which forms intercellular channels.

Pfeiffer syndrome

101600

FGFR2

Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.

Progeria

176670

LMNA

Waardenburg syndrome

193500

PAX3

Bilateral retinoblastoma

180200

RB1

Lamin A - structural protein forming the meshwork lining of the nuclear envelope
Transcription factor expressed in neural crest cells important for the migration and
differentiation of melanocytes.
Inhibitor of cell cycle progression.

Costello syndrome

218040

Multiple exstoses

133700

Muenke-type craniosynostosis

602849

HRAS
EXT1, EXT2,
EXT3
FGFR3

Neurofibromatosis 1

162200

Osteogenesis imperfecta

166200

Sotos syndrome

117550

NF1
COL1A1 or
COL1A2
NSD1

Thanatophoric dysplasia

187600

FGFR3

Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.

Treacher Collins syndrome

154500

TCOF1

Involved in ribosomal DNA gene transcription

Guanosine triphosphatase – acts as molecular switch that relays growth signals.
Endoplasmic reticulum-localised glycoprotein – tumor suppressor, enhances the synthesis of
cell surface heparan sulphate.
Growth factor receptor – regulates cell growth, proliferation, differentiation & survival.
Key inhibitor of the RAS proto-oncogene.
Collagen proteins – major extracellular structural protein.
Co-regulator of androgen receptor.

Table 3 - Paternal age effect syndromes in humans with corresponding mutated genes.

-

A brief overview of protein function listed. Syndromes marked in bold have “strong” paternal age effects (Risch et
al. 1987, Glaser & Jabs 2004).
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Syndrome
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Penrose’s copy-error hypothesis is an important factor in paternal age effect disorders.
However, the human diseases grouped together as those for which increasing paternal age has a
strong effect on the incidence rate apparently correspond to another category: cancer-like selfish
mutations which propagate themselves within the male germ-line.
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CHAPTER 3
HOMEOSTASIS IN STEM CELL LINEAGES

3.1 Introduction
The concept of the stem cell niche is one that is now pivotal to our understanding of how
most tissues are organised and maintained. Complex feedback networks allow tissues to selforganise and prevent the disorderly growth of cells.
Chapter 1 introduced the paternal age effect and the spectrum of human mutations. The
motivation for this chapter is to provide theoretical underpinning of normal, unmutated stem cell
division and to elucidate the dynamics that must exist in the feedback mechanisms that maintain
the homeostasis. Chapters 4 and 5 will discuss some of these signalling pathways involved and
how gain-of-function mutations can perturb the normal cell dynamic.
The goal of this chapter is to offer a mathematical model of tissue-level homeostasis
within a framework of a general stem cell system. While the focus is on germline stem cells, we
will discuss specific stem cell niches and the difference between them. Our model assumes cells
within a tissue belong to one of three compartments, the stem cell (SC) compartment comprised
of the stem cells themselves, the transit amplifying (TA) compartment, comprised of
intermediate differentiating cells that divide rapidly, typically with a limited lifetime, and the
differentiated cell compartment, which we assume contains the functional tissue cells that are
post-mitotic. We illustrate these compartments as physically distinct chambers but there is no
requirement for the compartments to be physically separated in the tissue. The dynamics of
individual compartments is dominated by three parameters, the rate at which cells divide, the rate
of apoptosis and the cell fate of the daughter cells. Our model reveals the intricate interplay
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between local and global equilibrium required for homeostasis of the tissue. These conditions for
homeostasis must be reflected in the feedback mechanisms in order for the net gain/loss of cells
to be constant.
Our main results include:
•
•
•
•

conditions required for homeostasis of the stem cell (SC) compartment;
conditions required for homeostasis of the transit amplifying (TA) cell compartment;
conditions required for homeostasis of the differentiated cell (post-mitotic) compartment
a proof that the TA compartment can only reach a homeostatic state if the stem cell
compartment is also in homeostasis.
We assume the existence of an integrated feedback mechanism responsible for

maintaining homeostasis at the tissue level. The local equilibrium equations spell out conditions
that the feedback mechanism must address. This model does not outline the feedback
mechanisms required to manage cell numbers but provides boundary conditions required for
homeostasis. We also assume that the signalling by which the feedback mechanism regulates the
biological processes in the tissue compartments occurs without appreciable delay. In the time
intervals between these pulses, the various compartment parameters remain constant.
3.2 The stem cell compartment
\
Let X0(t) denote the size of the SC compartment at time t ≥ 0, with X0(t) = n0 ≥ 1, where
n0 is the starting number of stem cells in the compartment. For h > 0, we let:
•
•

ν0(h) denote the fraction of the stem cells that divide in the interval (t,t+h];
γ0(h) denote the fraction of the stem cells that undergo apoptosis in the interval (t,t+h].

We assume that the two limits limh→0

ν 0 ( h)
h

and limh→0

γ 0 ( h)

exist and are finite. ν0

h

represents the rate at which stem cells divide. Similarly, γ0 represents the rate at which stem cells
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are lost to apoptosis (here we include all cell death or cell loss other than differentiation under
the umbrella of apoptosis). As mentioned in the previous section, we assume that over longer
time intervals under normal niche maintenance both ν0 and γ0 are constants. Since the following
ratio will appear quite often in our derivations, we find it convenient to write:

θ0 =

γ0
ν0

(1)

θ0 represents the rate of change of the cell numbers in the niche. In a simple system with only
stem cell symmetric divisions and apoptosis can occur, homeostasis requires θ0 = 1, higher and
the numbers will shrink, lower and the numbers will increase.
Stem cells, when they divide, have the possibility of dividing symmetrically and either
producing two stem cells or two differentiating cells, or asymmetrically and one of each daughter
cell is produced. At the niche level, we assume this process to be one that is stochastic for
individual cells but tightly controlled overall. For a dividing stem cell we let
•
•
•

α1 denote the probability that the cell produces two daughter stem cells;
α2 denote the probability that the cell produces one daughter stem cell and one TA cell;
α3 denote the probability that the cell produces two daughter TA cells;

Clearly:

α1 + α 2 + α 3 = 1

(2)

For later reference we observe that α1 ≠ 1 for normal tissue organisation, or no
differentiated cells can be made.
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In the above notation, ν0(h)X0(t) and γ0(h)X0(t) denote, respectively, the expected number
of stem cells that divide and those that undergo apoptosis in the time interval (t,t+h]. The size,
X0(t + h), of the SC compartment at time t + h can be expressed as:

X 0 (t + h ) = X 0 (t ) −ν 0 ( h) X 0 (t ) − γ 0 ( h ) X 0 (t ) + ν 0 ( h) X 0 (t ) [ 2α1 + α 2 ]
= X 0 (t ) + ν 0 ( h) X 0 (t ) [ 2α1 + α 2 − 1] − γ 0 ( h) X 0 (t )

(3)

= X 0 (t ) + ν 0 ( h) X 0 (t ) [α1 − α 3 ] − γ 0 ( h ) X 0 (t ) [by (2)]

After transposing X0(t) and dividing both sides by h we obtain:

X 0 (t + h) − X 0 (t ) ν 0 ( h)
γ ( h)
=
X 0 (t ) [α1 − α 3 ] − 0
X 0 (t )
h
h
h

(4)

which, upon taking limits as h→0, yields the differential equation:

dX 0 (t )
ν ( h)
γ ( h)
= lim 0
X 0 (t ) [α1 − α3 ] − lim 0
X 0 (t )
h →0
h →0
dt
h
h
= X 0 (t ) ν 0 (α1 − α3 ) − γ 0 

(5)

with the boundary condition X0(0) = n0. By solving (5) for X0(t) we obtain

ν (α1 −α3 ) −γ 0  t

X 0 (t ) = n0 e  0

We now take note of a conceptually useful result implied by (6).

(6)

30
Corollary 3.2.1: Unless θ0 < 1, the SC compartment cannot be homeostatic.
Proof: Since both α1 and α3 are probabilities, and since α1 ≠ 1, the difference |α1 - α3| is strictly less
than 1. As a consequence, γ0 ≥ ν0 implies γ0 ≥ ν0|α1 - α3| which, by (6), guarantees that X0(t) is a
decreasing function of time.
In turn, Corollary 3.2.1 confirms the intuitive feeling that if the SC compartment is to be
homeostatic then the rate at which stem cells are lost to apoptosis must be strictly smaller than
the rate at which they divide. However, this condition θ0 < 1 might be violated for short,
transient, periods of time in the wider context of time-dependent feedback mechanisms.

Fig. 5 - Illustrating the dynamics of the SC compartment

The dynamics of the stem SC compartment are illustrated in Fig. 5. We can determine
that:
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•

new stem cells are being produced as a result of cell divisions at the rate of
X0(t)ν0(2α2+α3) = X0(t)ν0[1+(α1–α3)];

•

stem cells are being lost to apoptosis at the rate of X0(t)γ0;

•

TA cells are being produced at the rate of X0(t)ν0(α2 + 2α3) = X0(t)ν0[1– (α1–α3)].

We are now in a position to state and prove the following fundamental result implied by
(6).

Theorem 3.2.2. A necessary and sufficient condition for homeostasis of the SC compartment:

α1 − α 3 =

γ0
= θ0
ν0

(7)

Proof: If (7) holds true, then ν0(α1–α3)–γ0 = 0 and so, by virtue of (6), X0(t) = n0, independent of t,
indicating that the SC compartment is homeostatic. Conversely, suppose the SC compartment is
homeostatic and therefore X0(t) = n0. (6) implies that ν0(α1–α3)–γ0 = 0 so (7) is validated. This
also makes intuitive sense. In a homeostatic state, the loss of stem cells to cell death must be
countered by symmetric stem cell division.

γ0
is a critical value as far as homeostasis of the SC
ν0
γ
compartment is concerned. Indeed, if α1 − α 3 > 0 the SC compartment grows exponentially. On
ν0
γ
the other hand, if α1 − α 3 < 0 then the SC compartment decreases exponentially.
ν0
At this point we observe that:
Theorem 3.2.2 indicates that θ 0 =

•

equation (7) is independent of n0, the original number of cells in the SC compartment. In
turn, this seems to suggest that any feedback mechanism that maintains SC compartment
homeostasis must act on ν0, γ0 or indeed the probabilities α1 and α3 subject to (7);
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•

as will be discussed later in some detail, the rate at which TA cells are produces by cell
division in the stem cell compartment depends on α1–α3. The lower α1–α3 is, the more TA
cells are being produced per unit time;

•

The probabilities α1 and α3 only occur in (7) through the expression α1–α3. This implies
that as long as the probabilities of symmetric divisions are shifted up or down by equal
amounts, homeostasis is preserved. This is reasonable: providing the requirements of
differentiating cell production and stem cell attrition replacement are met, it doesn’t
matter if the majority of stem cells divide with α2 asymmetrical divisions such as in the
drosophila germ cell niche (Chen et al. 2016) or a balance of α1 and α3 divisions as may
occur in the mammailian spermatogonial stem cell niche (de Rooij & Griswold 2012), the
balance of differentiating to stem cells is what matters. The feasible ranges for these
probabilities are investigated below.

 1 + θ0 
Lemma 3.2.3 For every value of α1 in the range θ 0 ,
there exist feasible probabilities of
2 


α2 and α3 that satisfy both (2) and (7).
Proof: We begin by justifying the stated range for α1. For this purpose, recall that by (2), 2α1 +
α2 = 1 + (α1 – α3). Since α2 ≥ 0, (7) leads to:

α1 ≤

1 + θ0
2

(8)

Combined with the fact that α1 ≥ θ0:

θ0 ≤ α1 ≤

1 + θ0
2

(9)

 1 + θ0 
To complete the proof, we need to show that for each value of α1 in the range θ 0 ,
2 


there exist probabilities α2 and α3 that satisfy both (2) and (7). To see that this is the case, we can
 1 + θ0 
assign α1 = u for an arbitrary u in the interval θ 0 ,
.
2 


By (7), the expression of α3 must be α3 = u – θ0. We can therefore observe:
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0 ≤ α3 ≤

1 + θ0
2

(10)

It also follows that α2 = 1 + θ0 – 2u. By our choice of u, then:

0 ≤ α 2 ≤ 1 − θ0

(11)

The expressions for α1, α2, and α3 obtained above satisfy (2) and (7) and the proof is complete.

Lemma 3.2.3 confirms our intuition that homeostasis of the SC compartment can occur
for a large number of values of α1 and, consequently, of α2 and α3. Moreover, as we shall show,
as long as the criteria for (7) are met, the rate at which new TA cells arise as a result of divisions
in the SC compartment is independent of the actual values of α1, α2, and α3. It is likely that
feedback mechanisms that keeps the SC compartment homeostatic favour some of these values
over others, there are undoubtedly other factors beyond purely the maintenance of homeostasis
that feature into the decision.
Next, we turn our attention to the rate at which TA cells are being produced within the
SC compartment..

Lemma 3.2.4 Under homeostatic conditions, the rate at which TA cells are being produced in the
SC compartment is n0 (ν0 – γ0).
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Proof: Recall that the rate at which TA cells are being produced by cell divisions in the SC
compartment is X0(t)ν0(α2 + 2α3). Consequently under homeostasis, we can write:
X 0 (t )ν 0 (α 2 + 2α 3 ) = n0ν 0 (α 2 + 2α 3 )
= n0ν 0 [1 − (α1 − α 3 )]
= n0ν 0 (1 − θ 0 ) [by (7)]

(12)

= n0 (ν 0 − γ 0 ) [by (1)]

Fig. 6 - Illustrating the dynamics of a homeostatic SC compartment.
New stem cells are produced at the rate of n0(ν0 + γ0), cells are lost to apoptosis at a rate of n0γ0
and TA cells are being produced at the rate of n0(ν0 – γ0). Once created, TA cells join the
dynamics of the TA compartment described in section 3.3.

3.3 The transit amplifying cell compartment

Let X1(t) denote the size of the TA cell compartment at time t≥0, with X1(t) = n1 ≥ 1. For
h>0, we let:
• ν1(h) denote the fraction of TA cells that divide in the interval (t,t+h];
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• γ1(h) denote the fraction of TA cells that undergo apoptosis in the interval (t,t+h].
We assume that the two limits limh→0

ν 1 (h)

and limh→0

h

γ 1 (h)

exist and are finite. In this

h

notation, ν1 represents the rate at which TA cells divide, while γ1 represents the rate at which TA
cells undergo apoptosis.
For a given dividing TA cell, we let:
•

β1 denote the probability that the cell produces two daughter TA cells;

•

β2 denote the probability that the cell produces one daughter TA cell and one terminally
differentiated cell;

•

β3 denote the probability that the cell produces two terminally differentiated cells.

As with the SC compartment:

β1 + β 2 + β 3 = 1

(13)

For some small h>0, let X1(t + h) denote the number of TA cells at time t+h. X1(t + h)
involves the following components:
•

X1(t) – ν1(h)X1(t) – γ1(h)X1(t): the TA cells in existence at time t that have undergone
neither division nor apoptosis in (t,t+h];

•

X0(t)ν0(h)[α2 + 2α3]: the new TA cells generated in (t,t+h] by divisions in the SC
compartment;

•

X1(t)ν1(h)[2β1 + β2]: the new TA cells generated in (t,t+h] by divisions of TA cells.

Therefore we can write these together as:
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X 1 (t + h) = X 1 (t ) −ν 1 ( h) X 1 (t ) − γ 1 ( h) X 1 (t ) + X 0 (t )ν 0 ( h) [ 2α 2 + α 3 ] + X 1 (t )ν 1 ( h ) [ 2 β1 + β 2 ]
= X 1 (t ) + X 1 (t ) ν 1 ( h ) ( β1 − β 3 ) − γ 1 ( h)  + X 0 (t )ν 0 ( h) [α 2 + 2α 3 ]

(14)

After algebraic manipulations of the above expression we obtain:

ν ( h)
X 1 (t + h) − X 1 (t )
γ ( h) 
ν (h)
= X 1 (t )  1 ( β1 − β 3 ) − 1  + X 0 (t ) 0 [α 2 + 2α 3 ]
h
h 
h
 h

(15)

which, upon taking limits as h→0, yields the differential equation:

dX 1 (t )
= X 1 (t ) ν 1 ( β1 − β 3 ) − γ 1  + X 0 (t )ν 0 [α 2 + 2α 3 ]
dt

(16)

with boundary condition X1(0) = n1.
By (6), the differential equation (16) with boundary condition X1(0) = n1 can be rewritten
as:

dX 1 (t )
− AX 1 (t ) = φ (t )
dt

where
•
•

A = ν1(β1 – β3) – γ1, and
ϕ(t) = n0ν0(α2 + 2α3)e[ν0(α1 – α3) – γ0]t = n0ν0[1 – (α1 – α3)]e[ν0(α1 – α3) – γ0]t

Using standard techniques, the solution of (17) turns out to be

(17)
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t
X 1 (t ) = e At  n1 + ∫ e− Auφ (u )du 
0



(18)

which, upon evaluating the integral, becomes

X 1 (t ) = n1e At + n0v0 1 − (α1 − α 3 ) 

ν (α1 −α 3 ) −γ 0  t

− e At
ν 0 (α1 − α 3 ) − γ 0 − A
e 0

(19)

where, recall, A = ν1(β1 – β3) – γ1.
We now state and prove a technical lemma that reveals the complexity of the feedback
mechanism at work in tissue lineages.
Lemma 3.3.1. If A = ν0(α1 – α3) – γ0 then the TA compartment cannot be homeostatic.
Proof: Suppose that this is not the case. Lemma A.2 in Appendix A guarantees that as A → ν0(α1
– α3) – γ0

ν (α1 −α 3 ) −γ 0  t

− e At
→ te At
ν 0 (α1 − α 3 ) − γ 0 − A
e 0

(20)

so the expression of X1(t) in (19) becomes:

(

X 1 (t ) = e At n1 + n0v0 1 − (α1 − α 3 )  t

)

(21)
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However this latter expression shows that X1(t) is a function of t. This remains true even if A = 0
in which case X1(t) = n1 + n0ν0[1 – (α1 – α3)]t grows linearly with t. This prohibits homeostasis
and completes the proof.
Observe that the conclusion of Lemma 3.1 is independent of whether or not the SC
compartment is homeostatic. The proof of Lemma 3.1 gives us a hint of the growth regimens
seen by the TA compartment if it is not in equilibrium. Refer to the Appendix for details.
The following useful corollary follows directly from the proof of Lemma 3.3.1.
Corollary 3.3.2 If the TA compartment is homeostatic then A≠0.
Next, recalling that A = ν1(β1 – β3) – γ1, Lemma 3.3.1 can be rephrased as follows:
Corollary 3.3.3 If

β1 − β3 =

γ 1 ν 0 (α1 − α 3 ) − γ 0
+
ν1
ν1

(22)

then the TA compartment cannot be homeostatic regardless of whether or not the SC
compartment is.
The dynamics of the TA compartment are illustrated in Fig. 7. Note that:
•
•
•
•

new TA cells are being produced as a result of TA cell divisions at the rate of X1(t)ν1[2β1
+ β2] = X1(t)ν1[1 + (β1 – β3)];
new TA cells are being produced by divisions in the SC compartment at a rate of
X0(t)ν0[1 – (α1 – α3)];
TA cells are being lost to apoptosis at the rate of X1(t)γ1;
differentiated cells are being produced at the rate of X1(t)ν1[β2 + 2β3] = X1(t)ν1[1 – (β1 –
β3)];
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Fig. 7 - Illustrating the dynamics of the TA cell compartment

As pointed out by several authors (Johnston et al. 2007, Lander et al. 2009, Tomlinson &
Bodmer 1995), accumulated empirical evidence suggests that if homeostasis is not present at the
SC compartment, then neither can the TA compartment be homeostatic. To our knowledge, this
phenomenon has not previously been proven.

Theorem 3.3.4 In order for the TA compartment to be homeostatic then the SC compartment
must also be homeostatic.

Proof: If the TA compartment is homeostatic, then X1(t) = n1 for all t ≥ 0. With algebraic
manipulation, (19) can be re-written as:
n1 1 − e At  =

n0 v0 1 − (α1 − α 3 ) 

ν 0 ( α1 − α 3 ) − γ 0

(e
−A

ν 0 (α1 −α 3 ) −γ 0  t

− e At

)

(23)
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where, as a direct consequence of Corollary 3.3.2

1 − e At ≠ 0

(24)

After dividing (23) by 1 – eAt and some simple algebra, n1 can be written as:

n1 =

ν (α −α ) −γ  t
n0 v0 [α 2 + 2α 3 ]
e  0 1 3 0  − e At
.
1 − e At
ν 0 (α1 − α 3 ) − γ 0 − A

n0 v0 1 − (α1 − α 3 )   1 − e ν 0 (α1 −α3 )−γ 0  t 
. 1 −
=

ν 0 (α1 − α 3 ) − γ 0 − A 
1 − e At


(25)

Since the TA compartment is homeostatic, the right-hand side of (25) must be
independent of t. Observe that:

n0 v0 1 − (α1 − α 3 ) 

ν 0 (α1 − α 3 ) − γ 0 − A

(26)

is a constant and therefore, in order for the right-hand side of (25) to be a constant, the
expression
ν (α −α ) −γ 0  t

1 − e 0 1 3
1−
1 − e At

(27)

must be a constant. By Lemma A.1 in Appendix A this happens if and only if ν0(α1–α3)–γ0 = 0.
However, by Theorem 3.2.2 this guarantees the SC must be homeostatic.
One last point needs clarification, namely that the conditions of Lemma A.1 in Appendix
A are verified. To confirm this with a = ν0(α1–α3)–γ0 and b = A we can see that:

41
•
•

by Corollary 3.3.2, 1 – eAt ≠ 0 and so b ≠ 0,
by Lemma 3.3.1, A ≠ ν0(α1 – α3) – γ0 and so a ≠ b,

confirming that Lemma A.1 does indeed apply. This completes the proof of Theorem 3.3.4.
We are now in a position to offer a necessary and sufficient condition for the homeostasis
of the TA compartment.

Theorem 3.3.5 The TA compartment is homeostatic if and only if the SC compartment is
homeostatic and, in addition,

β1 − β3 =

n1γ 1 − n0 (ν 0 − γ 0 )
n1ν 1

(28)

In biological terms this means that the net gain of TA cells must equal rate of loss minus
the rate of influx per cell division.
Proof: Firstly, if the TA compartment is homeostatic, then by Theorem 3.3.4, the SC
compartment is also homeostatic. Recall that by (7), α1 – α3 = γ0/ν0. Thus (25) can be re-written
as:

n0v0 1 − (α1 − α 3 )   1 − e ν 0 (α1 −α3 )−γ 0  t 
n1 =
. 1 −

1 − e At
ν 0 (α1 − α 3 ) − γ 0 − A 

 γ 
n0 v0 1 − 0 
 ν0 
=
−A
−n0 ( v0 − γ 0 )
=
v1 ( β1 − β3 ) − γ 1
With algebraic manipulation we can confirm that (29) yields (28).

(29)
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Conversely, we can assume that the stem cell compartment is homeostatic and that (28)
holds true. We therefore need to show that the TA compartment is also homeostatic. Since the
stem cell compartment is homeostatic, (7) along with Lemma A.1 (i.e. ν0 [α1 – α3] – γ0= 0)
guarantees the following:

n0v0 (α 2 + 2α3 ) = n0 ( v0 − γ 0 )
A = v1 ( β1 − β3 ) − γ 1 =

−n0 ( v0 − γ 0 )
n1

ν 0 (α1 − α 3 ) − γ 0 − A = − A =
ν (α1 −α 3 ) −γ 0  t

e 0

n0 ( v0 − γ 0 )
n1

− e At = 1 − e At

(30)

(31)

(32)

(33)

Upon replacing the values of these expressions back into (19), we obtain:

X 1 (t ) = n1e At + n1 1 − e At  = n1

(34)

confirming that the TA compartment is homeostatic. This completes the proof of the theorem.
This leads to the following observations:
•

•
•

•

The probabilities β1 and β3 only occur in (28) through the expression β1 – β3. This implies
that, provided the SC compartment is homeostatic, as long as the probabilities of
symmetric divisions are shifted up or down by equal amounts, homeostasis of the TA
compartment is preserved;
(28) relies on knowledge of the rate n0(ν0 – γ0) at which TA cells are being produced in
the SC compartment;
In contrast to the SC compartment, (28) depends on the size, n1, of the TA compartment.
In practice, this is achieved by a finite space in the niche architecture, so that TA cells are
limited by the presence of neighbours if the niche becomes full or by feedback
mechanisms (for example, Aoki et al. 2016)
(28) suggests that homeostasis of the TA compartment may occur in two mutually
exclusive ways, depending on the sign of the expression β1 – β3:
o Case 1: β1 – β3 ≥ 0, in which case the probability that a dividing TA cell produces
two daughter TA cells is larger than or equals the probability of producing two
differentiated cells;
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o Case 2: β1 – β3 < 0, in which case the probability that a dividing TA cell produces
two daughter TA cells is strictly smaller than the probability that it produces two
differentiated cells.

We assume that Case 2 is the normal circumstance of stem cell systems as Case 1
bypasses the need for stem cells altogether as transit amplifying cells would self-renew
indefinitely. However as discussed in the conclusions to this chapter, there is an argument for
Case 1 to occur in some stem cell systems.
For later reference, we now prove the following technical result.
Lemma 3.3.6 Under homeostatic conditions in the TA compartment

X1 (t )v1 ( β2 + 2β3 ) = n0 ( v0 − γ 0 ) + n1 ( v1 − γ 1 )

(35)

Proof: Under homeostasis, X1(t) = n1 independent of t. Thus we can write:

X 1 (t )v1 ( β 2 + 2β3 ) = n1v1 ( β 2 + 2β3 )
= n1v1 (1 − β1 + β3 )
= ( n0v0 + n1v1 ) − ( n0γ 0 + n1γ 1 ) [by Theorem 3.3.5]
= n0 ( v0 − γ 0 ) + n1 ( v1 − γ 1 )

completing the proof.

(36)
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Fig. 8 - Illustrating the dynamics of the TA cell compartment under homeostasis

Fig. 8 captures the dynamics of the TA cell compartment under homeostatic conditions. Indeed,
with n1 standing for the steady state number of TA cells:
•
•
•
•

new TA cells are produced by divisions in the TA compartment at the rate of n1(ν1 + γ1);
new TA cells are produced by divisions in the SC compartment at the rate of n0(ν0 – γ0)
TA cells are being lost to apoptosis at the rate of n1γ1;
terminally differentiated cells are being produced at the rate of n0(ν0 – γ0) + n1(ν1 – γ1).

3.4 The differentiated cell compartment

Let X2(t) denote the size at time t≥0 of the terminally differentiated (i.e. post-mitotic) cell
compartment. We assume X2(t) = n2 ≥ 0.
For h>0, let γ2(h) denote the fraction of the differentiated cell compartment that dies and
is shed in (t,t+h]. We assume that the limit limh→0

γ 2 ( h)

exists and is finite. γ2 represents the rate

h

at which differentiated cells die.
Referring to Fig. 9, let us consider what might happen in the time interval (t,t+h]:
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•
•
•

terminally differentiated cells do not divide and cannot self-renew;
X1(t)ν1[β2 + 2β3] new differentiated cells are added from the TA cells compartment;
X2(t)γ2(h) differentiated cells die and are shed.

Fig. 9 - Illustrating the dynamics of the differentiated cell compartment.

X2(t + h) can be broken into the following components

X 2 (t + h) = X 2 (t ) − X 2 (t )γ 2 (h) + X1 (t )v1 (h) [ β2 + 2β3 ]

(37)

which can be written as

X 2 (t + h) X 2 (t ) γ 2 (h)
v ( h)
X 2 (t ) + 1
X 1 (t ) [ β 2 + 2 β 3 ]
=
h
h
h

Upon taking limits as h→0 and using Lemma 3.3.6 we obtain the differential equation

(38)
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dX 2 (t )
= γ 2 X 2 (t ) = ( n0 v0 + n1v1 ) − ( n0γ 0 + n1γ 1 )
dt

(39)

with boundary condition X2(0) = n2.
Using standard techniques the solution of this differential equation turns out to be


( n v + n v ) − ( n0γ 0 + n1γ 1 )  + ( n0v0 + n1v1 ) − ( n0γ 0 + n1γ 1 )
X 2 (t ) = e−γ 2t  n2 − 0 0 1 1

γ2
γ2



(40)

3.4.1 Homeostasis of the differential cell compartment
We observe that there cannot exist homeostasis of the differentiated cell compartment
unless both the stem cell and TA compartments are homeostatic.
If we are to see homeostasis in the differentiated cell compartment, it must be that X2(t) =
n2 independent of t. In particular, this observation along with (40) allow us to write


( n v + n v ) − ( n0γ 0 + n1γ 1 )  + ( n0v0 + n1v1 ) − ( n0γ 0 + n1γ 1 )
n2 = e−γ 2t  n2 − 0 0 1 1

γ2
γ2



(41)

which, after suitable manipulations, yields

n2 1 − e−γ 2t  =

( n0v0 + n1v1 ) − ( n0γ 0 + n1γ 1 ) 1 − e−γ t 
γ2

Since γ2 ≠ 0, we can simplify the above to:



2



(42)
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n2 =

( n0v0 + n1v1 ) − ( n0γ 0 + n1γ 1 )

(43)

γ2

or, equivalently,

n0 v0 + n1v1 = n0γ 0 + n1γ 1 + n2γ 2

(44)

Observe that equation (47) tells us that the differentiated cell compartment is homeostatic
only if the expected number of stems cells and TA cells produced by division per unit time
matches the expected number of cells that die (in all compartments) per unit time.

3.5 Conclusions

The stem cell compartment is governed by the critical value θ 0 =

γ0
. This condition must
ν0

be met for homeostasis to occur within the compartment. In the special case where γ0 = 0 and
only symmetric divisions occur, that is α2 = 0, has been studied extensively in the literature
(Colijn & Mackey 2005, Johnston et al. 2007, Lander et al. 2009, Tomlinson & Bodmer 1995).
As several of these authors pointed out, in that particular case, homeostasis of the SC
compartment hinges on the very strong condition α2 = α2 = ½ which shows that the system is
inherently unstable.
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Fig. 10 - Summary of the model

It is noteworthy that this critical value is irrespective of the number of cells within the
niche and is controlled by the net gain/loss of new SCs under the balance of symmetric divisions
α1–α3 and there can exist a range of feasible values for α1 and α3 that satisfy the conditions for
homeostasis (see Lemma 3.2.3).
In order for the transit amplifying compartment to be homeostatic, the stem cell
compartment must also be homeostatic (Theorem 3.3.4). This has implications for modelling
developing stem cell systems as well as systems returning from a perturbation (e.g. wound
healing). Starting from a position of exponential growth, the system must reach equilibrium in
the stem cell compartment before (or alongside) the transit amplifying compartment. Similarly to
the SC compartment, the TA compartment must balance self-renewing divisions against the
influx from the SC compartment minus the loss to apoptosis. See (28). As might be expected,
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homeostasis in the TA compartment relies on the niche balancing the rate of production of TA
cells in the SC compartment. Unlike the SC compartment, the balance of differentiating vs. self
renewing symmetric divisions in the TA compartment depends not only on the number of TA
cells but the number of SC cells as well.
The dynamics of the TA compartment can be in equilibrium in one of two mutually
exclusive arrangements, depending on the balance of symmetrical self renewing divisions (β1) to
symmetrical differentiating divisions (β3). Case 1: β1 – β3 ≥ 0 and Case 2: β1 – β3 < 0.
Case 2 seems to be the normal circumstance by which the stem cell system operates (e.g.
colonic crypt), as Case 1 would mean that the stem cells do not divide and are not required for
TA compartment homeostasis unless the compartment’s balance is disturbed in some fashion.
However, while it may seem counter-intuitive that you might have a stem cell system without
stem cell divisions, Case 1 may occur in some systems, for example the spermatogonial stem cell
nice. In the scenario of Case 2, stem cells would not divide, but given a disruption in the TA
compartment such that β1 – β3 < 0 no longer held true, then stem cells would recommence
division. Within the spermatogonial stem cell niche, there are two populations of stem cells, Adark
cells that are quiescent and Apale stem cells that divide continuously and give rise to
differentiating progeny (Yoon et al. 2009). When the Apale population is reduced through
radiation, the Adark cells activate and become Apale cells (van Alphen et al. 1988). Within the
context of our model, the Apale cells, although commonly regarded as the spermatogonial stem
cells, are what we would term as the long-lived TA cells in the unusual Case 2 scenario and the
Adark cells are the true stem cells.
The differentiated stem cell compartment is fairly straightforward. The TA compartment
must produce enough differentiated cells to offset loss in the differentiated compartment.
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However an interesting result per equation (47) is that homeostasis in the differentiated
compartment requires that the total number of stem cells and transit amplifying cells produced at
any given time must offset the loss in all compartments to cell death.
The model presented in this chapter is a novel model for a generic stem cell system and
details boundary conditions for homeostasis that must be adhered to via cell feedback
mechanisms in order for equilibrium to be reached. Unlike previous work this model does not
assume any arbitrary determination of cell fate after division and allows for both symmetric and
asymmetric cell division. It is noteworthy that this model allows for a great variety of cell
divisions patterns and symmetric stem cell divisions (α2) are unimportant for homeostasis as long
as the boundary conditions are met for homeostasis. This allows the number of α2 divisions to
vary wildly and indeed in practice we can see in nature, even within the spermatogonial stem cell
niche, systems that seem to be chiefly symmetric like germ-line stem cell divisions in drosophila
(Chen et al. 2016) to largely symmetric divisions such as the mammalian stem cell niche (Klein
et al. 2010).

51
CHAPTER 4
SELECTIVE MUTATION ACCUMULATION:
A COMPUTATIONAL MODEL OF THE PATERNAL AGE EFFECT

4.1 Introduction to the model

This chapter presents a mathematical model to simulate the accumulation of mutations in
the spermatogonial stem cell (SSC) niche due to replication errors and premeiotic positive
selection.

4.1.1 The Spermatogonial Stem Cell Niche

SSCs reside on the basal lamina on the outer edge of the seminiferous tubules within the
testes. Spermatogonia are surrounded by much larger Sertoli cells that form the
microenvironment for the cells. The spermatogonia divide in cyclical waves and progeny of the
stem cells migrate as they divide and differentiate towards the hollow centre of the seminiferous
tubule (de Rooij & Russel 2000). In humans the active SSCs are comprised of type Apale
spermatogonia (so named to differentiate between those spermatogonia that cycle continuously
and the Adark undifferentiated spermatogonia that are quiescent, although both sets seem to have
stem cell properties).
Certain stem cell systems like the colonic crypt have specific arrangements of cells with
strictly limited numbers of stem cells (Humphries & Wright 2008). The SSC niche on the other
hand lacks obvious repeating structures. However, SSCs are observed to localise to specific areas
of the seminiferous epithelium (Yoshida 2008). While spermatogonia can repopulate whole
seminiferous tubules that have been depleted by radiation (Shinohara et al. 2001), studies of live
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imaging of stem cells indicate limited migrational capabilities (Klein et al. 2010). Additionally,
cells that migrate away from the niche are likely to differentiate (de Rooij & van Beek 2013),
likely because GDNF distribution is patch-like (Sato et al. 2011), creating effective niche limits.

4.1.2 Motivation & Predictions

The objective of this model was to simulate the accumulation of mutations through
positive selection. The magnitude of the selective effect (r) has not been determined
experimentally, although it has been estimated to be 0.014 for the FGFR2 mutations causing
Apert’s syndrome by Yoon and colleagues in earlier models based upon spatial arrangement of
mutations (Yoon et al. 2009, Choi et al. 2008, Qin et al. 2007). This corresponds to an expansion
of mutant stem cells over wildtype occurring with a probability of 1.4% with every division of a
mutant cell.
Our primary aim was to estimate the r value for a range of disease causing mutations. We
hypothesised that diseases with a more exponential increase with paternal age would have larger
r values. We also aimed to determine if differences in incidence rate between alleles of a single
gene or between mutations that cause different disorders is due to the underlying mutation rate or
to the selective advantage of the particular alleles. Additionally, where different mutations affect
the same gene, if there is a stronger activating mutation, we expected a higher r value.
The SSC niche has been the subject of some computer simulations of the normal stem
cell niche (de Rooij & van Beek 2013, Ray et al. 2014) and also in terms of mutation
accumulation by positive selection for Apert syndrome (Yoon et al. 2009) but no models have
mathematically modeled the accumulation of mutation or looked at mutation accumulation
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in state 0. Once in state 1,, the pprobability of advancing to state 2 has changed
change to p1 as the chance
of mutation remains but the m
mutant cells may expand with a selective
ve event.
eve Correspondingly,
the chance that a cell division
ision occurs
o
that maintains the niche in state 1 is no
now q1. This continues
until, ultimately, all of the n cells
cel are mutant, at which point the system remains
rema in state n.
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We have modeled the system as a Markov chain (Fig. 11). The chain has n+1 states,
where state 0 represents the niche comprised entirely of wildtype cells and in the final state, n,
the cells are entirely mutant. Cells are selected at random from the niche to divide sequentially.
State i represents the niche with i mutant cells and n-i wildtype cells. In state i there is within the
niche a probability pi that after a cell division the number of mutant cells will increase by one,
and a probability qi that they will remain the same. The probability of a mutation and a
subsequent reversal at the same site is sufficiently small as to be ignored.
Let us imagine that the niche is in state i and a random cell is selected to divide. If the
cell selected is wildtype, then with probability p it is transformed into a mutant and returned to
the niche, otherwise it is returned as a wildtype. If a mutant cell is selected, it is simply returned
to the niche unless a selection event happens with probability r, in which case two mutant cells
are returned and subsequently one random cell is lost (all cells including the returned cells are
eligible to be lost).
In order to calculate qi, the probability that after a cell division the system remains in
state i, there are therefore three mutually exclusive possibilities with the following probabilities:
(1)

A wildtype cell is selected for division, but no mutation occurs:
n−i

(1 − p )

n

(2)

(45)

A mutant cell is selected for division and no selection event happens:
i
n

(1 − r )

(46)
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(3)

A mutant cell divides, a selection event happens and a mutant cell is lost from the

niche.
i

r

n

i +1

(47)

n +1

The combined probability qi is therefore:

qi =

n−i

(1 − p ) + (1 − r ) +

i

i

n

n

n

r

i +1
n +1

(48)

With some rearrangement:
qi = 1 − p +

 p − r (n − i) 


n
n +1 
i

(49)

Since pi = 1 – qi, this can be rewritten as:
pi =

n−i
n

 p + ir 
 n + 1 

(50)

The Markov chain produces a matrix, T, with dimensions of (n+1) × (n+1), where rows
indicate the starting state and column denote the final state (i.e. the initial and final number of
mutant cells).

q
0

0

= 0

⋮

0
 0

0

T

p0

0

0

⋯

0

0

q1

p1

0

⋯

0

0

0

q2

p2

⋯

0

0

0

0

q3

⋯

0

0

⋮

⋮

⋮

⋱

⋮

⋮

0

0

0

⋯

q n −1

p n −1

0

0

0

⋯

0

1












(51)
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This matrix (51) gives the probability of moving from one state to another in one step i.e.
one cell division within the stem cell niche. The element Tij gives the probability of starting in
state i (i.e. a niche containing i mutant cells) and after one cell division in the niche ending in
state j with j mutant cells. In order to model the progression of multiple cell divisions within the
niche, the matrix can simply be raised to the power of the number of cell divisions. T2 will give a
matrix that provides probabilities for two steps (i.e. two cell divisions within the niche) and TK
will provide probabilities for traversing in K steps. In the final matrix, therefore, the element TKij
represents the probability that a niche starting with i mutant stem cells will end with j mutant
stem cells after K cell divisions. Note that K is total cell divisions occurring amongst any of the
cells in the niche, not the average number of divisions per cell, which would be K/n.
For an individual, the number of steps required, K, is a factor of the rate of cell division d
(divisions per year per cell), the age of the individual a in years and the number of cells per niche
n.

K = nda

(52)

The matrix TK was for any given age solved computationally, by generating a matrix T
and calculating values for each cell and then raising the matrix to the power K. Since the model
assumes every individual starts with 0 mutant cells, the only relevant part of the final solved
matrix is the top row.
State
PS

[

0

1

2

3

…

n −1

n

P0

P1

P2

P3

…

Pn −1

Pn

]

(53)

For a given state s, the value Ps denotes the probability that starting with 0 mutant cells,
after K cell divisions, the niche will have s mutant cells. The average number of mutants per
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niche (assuming sufficient number of replications), M, can be calculated by summing all of the
final state values multiplied by the corresponding probabilities.
n

M =

∑ sP

S

(54)

s =0

M/n gives us a single proportion of mutant to wildtype cells at a given age a. Within an
individual person many niches will deviate dramatically from the average value, but since the
number of niches within a single individual can be assumed to be high (see section 2.3), but all
contribute sperm equally, we can assume that the overall proportion of mutant sperm to wildtype
sperm as a whole will tend towards to M/n.
This can be proven as follows. There are N niches each with n stem cells. Each niche has
a different number of mutant cells, u1, u2, etc. Each stem cell contributes an equal number of
sperm, for simplicity we assume one sperm per stem cell but the following is true for any value
of sperm produced per stem cell division as the proportion will remain constant.
The total number of mutant cells U is:
N

U =

∑u

i

(55)

i =0

Dividing by the total number of stem cells over all the niches (Nn) gives the proportion of
mutant stem cells over total cells, which is equivalent to the mean proportion of mutant cells per
niche:
U
Nn

Where

X

U

=

XU
n

(56)

is the mean number of mutant cells per niche for a given number of niches N.

Taken to the limit:
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X =

 n 

lim 
N →∞

U

M
n

(57)

Therefore using the ideal average value M/n from a single niche is an accurate measure of
mutant sperm proportion for the entire individual providing N is large and all niches contribute
sperm equally.

4.2.2 Confirmation of Model Design by Simulation

To test the mathematical model, we designed a simulation alongside it to emulate the
progression of a single stem cell niche. Early versions of our simulation were much more
complex and attempted to simulate all the SSCs within an individual, but simulation of a single
niche is sufficient to test the model, particularly averaged over a large number of repeats (see
equation 2.13). Simulation of the stem cell niche was designed in C++. Script design simulated a
stem cell population at a niche level independent of the Markov chain model (supplementary
algorithm 1).
The simulation progressed by selecting a random cell. If the selected cell was wildtype it
became mutant with probability p and if the selected cell was mutant it underwent a selective
event with probability r. Selective events represented a symmetric division and added a mutant
cell to the niche. As a consequence a random cell was then ejected and lost from the niche. This
process was repeated and the simulation was allowed to run for a specific number of cell
divisions sufficient to represent a human reproductive lifespan (n×d×80 years). The results from
each run were then averaged over a hundred thousand repeats of the simulation.
The simulation was tested against the mathematical expression by applying equation 2.10
with the same parameters and age values as the simulation. The simulation tended towards the
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values provided by the model and showed perfect agreement with sufficient replication
(supplementary Fig. B.2).

4.2.3 Parameters

Mutation probability, p. Rahbari et al. (2016) estimated the mutation frequency per
nucleotide per germline cell division at 4 × 10-11 calculated by sequencing multi-sibling families.
This mutation rate is close to that calculated with phylogenetic data (Lynch 2010) and point
mutations on the Y-chromosome (Helgason et al. 2015). Rahabari and colleagues also noted
little variation of mutation rate with paternal age, which allowed us to assume p is a constant
value regardless of age. This is the baseline mutation probability per site, before accounting for
elevated mutational frequency due to CpG sites or multiple disease-causing alleles within a
single gene.

Stem cells per niche, n. SSCs are not organised in regular repeating structures with
defined cell numbers like the colonic crypt (Humphries & Wright, 2008) and this makes
estimating the niche size difficult. While initial models of the SSC niche did not have discrete
compartmentalization, recent research has shown preferential clustering of SSCs to specific
regions of the seminiferous basal lamina (de Rooij & Griswold 2012, Yoshida et al. 2007). To
estimate the number of SSCs per niche, we turned to studies in mice, where spermatogenesis has
been reconstituted in sterile mice by transplantation of SSCs bearing a reporter gene. From
Shinohara et al. (2001), adult mice generated at least 108 colonies per testis. Given 35,000 stem
cells per mouse testis (Tegelenbosch & de Rooij DG 1993), this amounts to 324 stem cells per
niche. Scaling up to human testes by weight, assuming the same number of stem cells per niche,
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gives us approximately 3 million individual niches, which fulfills the requirement of equation
2.13. The model also assumes the number of SSCs remains constant throughout life. In reality,
the number of stem cells declines with age (Paul & Robaire 2013). Assuming attrition occurs
evenly among mutant and wildtype stem cells, this stochastic loss will not affect the proportion
of mutant to wildtype sperm over many niches. The caveat to this is that it is possible that the
mutant cells, rather than a proliferative advantage, are granted some form of resistance to the
age-based attrition. Finally, as hypothesised by Yoon and colleagues (Yoon et al. 2009), nonproliferating Adark spermatogonia may activate as reserve stem cells and replace losses (including
lost mutant cells) with wildtype cells. In Chapter 1, this would represent a Case 1 system, see
equation (28) in Theorem 3.3.5. However with cell death of the long-lived transit amplifying
Apale cells, the balance of (β1 – β3) divisions would shift to a Case 2 dynamic and necessitate the

activation of Adark cell division to replace them. This would cause a “dip” in the mutation
frequency, irrespective of gene as fresh wildtype cells are introduced into the system. This is
beyond the scope of this model, however the implications are discussed in Appendix B.

Stem cell divisions per year, d. Human spermatogenesis results in one stem cell
divisions per spermatogenic cycle of the Apale spermatogonia, so once every 16 days (de Rooij &
Russel, 2000), although lower estimates exist (Tomasetti & Vogelstein, 2015). The model selects
cells to divide randomly rather than in waves, however the odds of the same cell being selected
repeatedly is low and the results are averaged over a large number of niches, the effect of this is
negligible and allows us to avoid tracking individual cells.

Selection pressure, r. This is the probability that a mutant stem cell will divide
symmetrically and self-renew. As this value has not been determined experimentally, the model
fits a best-fit curve for the optimal r value to fit the data. Note that in normal steady-state
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division, SSCs may divide symmetrically into Apaired spermatogonia where both daughter cells
remain stem cells or both differentiate (de Rooij & Griswold 2012) for which there is some
evidence (Klein et al. 2010). For simplicity we have assumed, as earlier models have done (Yoon
et al. 2009), that each stem cell divides asymmetrically in normal homeostatic cell division rather

than a balance of differentiating and self-renewing divisions.

4.2.4 Fitting the Model to Mutation Data

In order to match our model to existing paternal age effect data, we started with birth
incidence of various genetic diseases. The larger number of younger parents versus older ones is
accounted for by looking at Observed/Expected values, the number of births for a given age
category divided by the expected number of births assuming the total number of disease-affected
children were distributed to each age category proportional to births in that population.
Using census data from 1966 USA birth data (Vital Statistics of the United States, 1966,
U.S. Department of Health, Education and Welfare) to estimate a number of births per age
category, Ca, (as per Risch et al. 1987). 1966 most closely matched the birth data used. The
fraction, M/n, of mutant-to-wildtype sperm for the given age category was used to derive a
number of disease-affected births for that category, simulated mutant births (S).
S =

M
n

Ca

(58)

By dividing the number of fathers in the age category by the total population and then
multiplying this proportion by the total number of simulated mutant births, we can calculate the
predicted mutant births (P) assuming simulated mutant births are distributed proportional to the
paternal age distribution.
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P=

Ca
Ct

∑S

(59)

Simulated/Predicted is therefore directly comparable to the Observed/Expected data.
In order to fit the S/P data to the existing O/E values, the strength of selection, r, had to
be empirically determined. A script was generated in R (R Development Core Team, 2008) that
would match the O/E values according to the following algorithm:
(1)

For a given value of r, calculate a single S/P value for the median age of

the following age categories: 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54. In each case
the average age for the category was used to generate the S/P value.
(2)

Calculate the difference between each S/P value and the corresponding

O/E value. Take the sum of squares (SOS) of these differences. .
(3)

The process was optimised for r using R’s optim function by searching for

the r value with the lowest SOS score.
We also compared our model to high-throughput sequencing data. In this case,
proportional numbers of mutant sperm were compared directly to the model’s predicted
proportion of mutant stem cells to wildtype cells. The same procedure as above was used, except
instead of SOS of O/E-S/P, the number of mutant cells per 106 cells was used directly and the
SOS between experimental and calculated number of mutants was generated.
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Fig. 12 - Simulation of observed/expected birth numbers.
FOP – fibrodysplasia ossificans progressiva, TD – thanatophoric dysplasia.
O/E disease data from Risch et al. (1987), except for Costello syndrome (O/E ratios calculated
from Lurie 1994), achondroplasia and thanatophoric dysplasia from Orioli et al. (1995).

4.3 Results
Fig. 11 shows the matched model and disease data graphs for 8 disorders that show a
strong paternal age effect. Excluding FOP as an outlier (see discussion), the remaining predicted
incidence values correlated significantly with the actual incidence values (Pearson’s correlation
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coefficient = 0.91, p<0.05). With those disorders where sequence data is available (Costello,
Apert and thanatophoric dysplasia syndromes), r values can be compared directly between
disease data and sperm mutation rates and show close agreement (TOST equivalence test,
ε=0.0053, p<0.05). The probabilities of positive selection varied from 0.5% to 1.5% with a mean
r value of 0.0083 for r values from birth data and 0.0094 from sequence data.

The predicted incidence rate is shown in table 2. The raw incidence assumes the baseline
mutation rate p of 4 × 10-11. However, mutation rate varies by location in the genome and the
sequence in question and of particular interest are CpG sites. These are particularly mutable as
cytosine in CpG sites is a methylation site and can spontaneously deaminate to thymine (Lynch
2010). In order to account for the increased mutation chance, the probability of CpG-specific
alleles mutating was multiplied by a factor of 15 for a transition or 5 for a transversion
(Nachman & Crowell 2000). Additionally, a number of paternal age effect disorders are caused
by multiple mutations at a variety of loci and by looking at disease incidence of the disorder as a
metric, we include all mutations that contribute to that disease phenotype. In order to simulate
this in the model, the aggregate probability of mutation, pa, is the probability of any of the
mutations occurring that give rise to the phenotype, with the formula:

pa = 1 −

( (1 − p ) )
a

(60)

Where p is the baseline mutation probability and a is the number of potential mutation
sites that can produce mutant alleles.
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r value

r value

Gene

(sequencing data)a

(birth data)b

Achondroplasia

FGFR3

-c

0.00741

Apert’s syndrome

FGFR2

Disease

(C755G) 0.0124
0.00888
(C758G) 0.0126
Costello syndrome

HRAS

(G34A) 0.00526

0.00606

Crouzon syndrome

FGFR2

-

0.00997

FOP

ACVR1

-

0.0135

Marfan syndrome

FBN1

-

0.00517

Pfeiffer syndrome

FGFR2

-

0.00668

TD

FGFR3

(A1948G) 0.0105

0.00937

Table 4 - Strength of positive selection (r) for 8 diseases
FOP – fibrodysplasia ossificans progressiva, TD – thanatophoric dysplasia.
a
Calculated by directly matching mutation incidence to that from sperm DNA sequencing (see
Fig. 12), specific mutation is shown in parentheses.
b
Calculated from birth incidence rates by making the best fit of O/E curves, with adjusted
mutation rates (see Fig. 11).
c
Several studies have estimated the mutation rate of achondroplasia in sperm but have been
omitted due to concerns of the methodology (Maher et al. 2014).

4.4 Discussion
We hypothesised that one of the two Apert’s syndrome-causing mutations (C755G) has a
higher incidence than the other (C758G) because the former occurs at a CpG dinucleotide, which
has a higher mutability due to spontaneous deamination. Our results support this hypothesis as
both of the Apert mutations have a very similar r value with 0.0124 for C755G compared with
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0.0126 for C758G. These two distinct amino-acid substitutions (S252W and P253R) appear
therefore to have the same selective effect on the cell and the increased incidence of S252W is
purely because of increased mutability at this site. The projected incidence rate is very sensitive
to the model parameters and particularly the mutation rate. For example, achondroplasia has a
high incidence rate relative to the other diseases (1 in 27,000, see table 2). The computed r value
on the other hand was middle of the range, which failed to account for the high incidence rate
when the baseline value for p was used. Once the value of p was increased to the level of a C→T
transition, the predicted incidence agreed well. So the site-specific mutation rate accounted for
the relatively high incidence rate of this disease.
The predicted incidence rates, after accounting for the number of alleles and the mutation
rate, present close to the actual values, with the exception of fibrodysplasia ossificans
progressiva. This disease is anomalous as it is a very rare disease (one in 2 million births) but it
is predicted to have a high incidence rate as it is caused by a transition at a single CpG site
(Shore et al. 2006). While the rates of substitution vary by location in the genome, including the
rates at CpG sites (Mugal & Ellegren 2011, Fryxell & Moon 2005), it is unlikely the substitution
rate could be low enough at this point, even if unmethylated. It might be explained by a very low
selective advantage but the projected r value is high (0.0135), producing an O/E curve similar to
achondroplasia. The low birth prevalence is also not explained by low survival to term of
affected offspring as FOP does not show severe symptoms until later in life or by any variation
of expression of the mutant allele as it shows complete penetrance (Petrie et al. 2009) so the low
incidence rate remains unexplained.
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Fig. 13 - Rates of mutants
ts per million sperm with age.
Apert syndrome (Yoon et al. 2009),
20
Costello syndrome (Giannoulatou ett al. 2013),
Thanatophoric dysplasia (TD) aadapted from Goriely et al. (2009).

The mutations causin
causing thanatophoric dysplasia and achondr
hondroplasia both cause
constitutive activation off the FGFR3 but TD mutations activate thee receptor
rec
more strongly,
leading to a more severe
re phe
phenotype (Naski et al. 1996, Bonaventure
ture et al. 2007). We can
therefore predict the r value
lue for TD to be higher than that for achondroplasia
oplasia, which is confirmed
by our model (TD r = 0.0105
.0105, achondroplasia r = 0.00741). Note that both
bo sets of data were
taken from one study (Orioli et al. 1995) in order to ensure that they are
re comparable.
com
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Literature Incidence

Disease
Incidence Rate

Incidence Rate

Rate

Alleles

Adjusted Predicted

Reference

Raw Predicted

ACH

1 in 400,000

1 in 27,000

1 in 26,000

[1]

1

Apert

1 in 700,000

1 in 130,000

1 in 100,000

[2]

2

Costello

1 in 2,300,000

1 in 160,000

1 in 300,000

[3]

14

Crouzon

1 in 600,000

1 in 37,000

1 in 60,000

[4]

16

FOP

1 in 340,000

1 in 23,000

1 in 2,000,000

[5]

1

Marfan

1 in 3,400,000

1 in 68,000

1 in 70,000

[6]

50

Pfeiffer

1 in 1,600,000

1 in 130,000

1 in 100,000

[7]

12

TD

1 in 720,000

1 in 60,000

1 in 40,000

[8]

12

Table 5 - Incidence Rates of 8 Diseases
ACH – achondroplasia, FOP – fibrodysplasia ossificans progressiva, TD – thanatophoric
dysplasia.
Raw predicted incidence rates calculated with a baseline mutation rate of 4 ×10-11.
Adjusted rates account for variation in mutation rate at CpG dinucleotides and the number of
mutable alleles that cause the disease phenotype. Alleles denote the number of most common
genetic variants that comprise at least 95% of cases of the disease. (Online Mendelian
Inheritance in Man, 2016). Incidence rates of ACH is a mean value between 0.36 and 0.6 per
10,000 after accounting for 20% of ACH cases being inherited from an affected parent. Sources:
[1] Faruqi et al. 2014, [2] Blank 1960, [3] Lurie 1994, [4] Helman et al. 2014, [5] Hüning &
Gillessen-Kaesbach 2014, [6] Lynas 1958, [7] Vogels & Fryns 2006, [8] Connor et al. 1985.

In a previous model, Yoon and colleagues estimated r to be 0.014 (Yoon et al. 2009) and
our model presents a value close to that based on their sequencing data (r = 0.0125), although the
value from birth data was lower (r = 0.00888). It is noteworthy that these values for Apert’s
syndrome were higher than the average value for the other disorders.
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The model presented in this chapter provides a mathematical understanding of the
accumulation of selfish disease-causing mutations. We have successfully predicted the incidence
rates of different diseases based on O/E curves and information of the molecular nature of the
mutations and estimates for the strength of selection. The selective advantage granted by these
mutations is the most important factor in terms of the exponential increase over time but the sitespecific mutation rate and the number of mutable sites plays a key role in how common the
disease is at the population level.
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CHAPTER 5
INVESTIGATION INTO THE PROLIFERATIVE ADVANTAGE OF RET M918T
MUTATIONS IN HUMAN SPERMATOGONIAL STEM CELLS

5.1 In Vitro Analysis of the Paternal Age Effect
Investigations into the cause of the paternal age effect have focussed on two diseases,
achondroplasia and Apert’s syndrome, both caused by single SNPs in the FGFR2 and FGFR3
genes respectively, and have concentrated in analysing mutation distribution patterns in human
testes (Qin et al. 2007, Yoon et al. 2009, Dakouane Giudicelli et al. 2007). These studies rely on
sampling sperm or testes cells and extrapolating a causative nature to the mutations. No in vitro
or animal model of premeiotic germ cell selection has been created, and while many other
candidate genes exist, no others have been studied.
The hypothesis that mutations expand in the germline prior to mitosis requires a
functional effect of the mutation on stem cell division. Spermatogonial stem cell division is
tightly regulated, typically dividing into two daughter cells with different fates. Traditional stem
cell theory holds that one remains a stem cell, maintaining the stem cell population within the
niche; the other divides and differentiates into spermatocytes. This asymmetric cell division is
controlled by extracellular signals that activate certain signalling cascades. More recent research,
however, suggests that some of the early differentiating forms can retain stem-cell capacity and
may be able to recolonise a stem cell niche. (Barroca et al. 2009). Recurrent paternal age effect
mutations are often the same as found in cancer (see Fig. 14).
While the full details of the cues and controls determining spermatogonial stem cell fate
are a subject of active research, glial cell derived neurotrophic factor (GDNF) is undoubtedly a
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key player that dictates whether any given stem cell will differentiate, divide asymmetrically or
divide symmetrically to produce two new stem cells (Sariola & Saarma 2003). Produced by the
Sertoli cells surrounding the spermatogonial stem cells, GDNF is essential for maintaining
normal stem cell division: high GDNF dosage is associated with spermatogonial stem cells
dividing symmetrically (Sariola & Saarma 2003). Mice overexpressing GDNF show
accumulation of undifferentiated spermatogonia and eventually display nonmetastatic testicular
tumours (Meng et al. 2000).
The gene of interest was selected on the basis of the following criteria; (a) strong paternal
age effect and connection to canonical growth signalling pathway, (b) disease phenotype caused
by highly recurrent (>90% of disease incidence) single base pair mutation and (c) connection to
known factors associated with stem cell renewal. Prime candidates were FGFR2 C755G (Apert’s
syndrome), FGFR3 G1128A (achondroplasia), RET T2943C (multiple endocrine neoplasia type
2B) and ACVR1 G617A (fibrodysplasia ossificans progressiva), which fulfill all criteria. SSCs
themselves represent an invaluable stem cell model system given their ease of access in vivo and
as germline cells their DNA will ultimately be passed on to the next generation, crucial for both
natural and bioengineered hereditary traits.
This investigation’s results will have impact in understanding the specific causes of the
high de novo incidence of MEN2B, the paternal age effect in general as well as broader
questions concerning spermatogonial stem cell disregulation.
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Fig. 14 - Incidence rates in four
fou genes of mutations in 6 genes
Each incidence of a particular
cular m
mutation is noted and colour-coded. Data
ta was compiled from
OMIM (germline data - http://w
ttp://www.omim.org/) and COSMIC (cancer data:
http://cancer.sanger.ac.uk/cosm
/cosmic)
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5.2 Methods
5.2.1 Induced Pluripotent Stem Cell (iPSC) creation

iPSCs were a kind gift from Patrick Sachs and Peter Mollica (per established techniques,
e.g. Fusaki et al. 2009). To briefly summarise their work in manufacturing the iPSCs, they were
created using the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Invitrogen). Briefly, human BJ
cells were transiently transfected with the proprietary construct that did not integrate (IBC #13021). Tests were performed to ensure (1) they were endogenously expressing pluripotency
markers, (2) all of the virus was removed from the cells, (3) they differentiated into each dermal
lineage and (4) they expressed TRA-1-81 and positive for alkaline phosphatase activity. For
iPSC-BJ passaging, initially manual passaging was conducted to eliminate MEF contamination,
and subsequently we used enzymatic passaging with dispase. iPSCs were maintained on MEF
(mouse embryonic fibroblast) feeder layers and supplemented with KSOR media.

5.2.2 Differentiation into Spermatogonial Stem Cells

iPSCs were differentiated by applying SSC media, changed daily, to iPSC colonies for 10
days before passaging, per Easley et al. (2012). SSCs were mainted on STO feeders. STO
feeders (SNL 76/7, mitomycin C treated, Applied StemCell Inc) were plated at a concentration of
5×104 cells/cm2 (typically plated at a concentration of 2×105 cells/ml). STOs were cultured in
DMEM supplemented with 15% FBS for at least 24 hours before plating SSCs. SSCs were
cultured in 6-well plates in SSC media changed every 1 day initially and every 2 days once
established.
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Reagent

Manufacturer

Concentration

α-MEM

GIbco

Basal media

Penicillin

Sigma

50 units/ml

Streptomycin

Sigma

50 units/ml

Bovine serum albumin (BSA)

Calibiochem

0.2%

Transferrin

Sigma/Gibco

10 μg/ml

Linolenic acid

Sigma

5.6 mM

Oleic acid

Sigma

13.4 mM

Palmitoleic acid

Sigma

2.3 mM

Linoleic acid

Sigma

35.6 mM

Palmitic acid

Sigma

31.0 mM

Stearic acid

Sigma

11.6 mM

Na2SeO3

Sigma

3 × 10-8 M

L-glutamine

Sigma

2 mM

Insulin

Gibco

25 μg/ml

HEPES

J. T. Baker

10 mM

Putrescine

Sigma

120 μM

2-mercaptoethanol

Sigma

120 μM

Recombinant human GDNF

Gibco

20 ng/ml

rat GFRα1

Gibco

150 ng/ml

human bFGF

Gibco

20 ng/ml

Table 6 - Standard SSC Media
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5.2.3 Immunocytofluorescence.

DDX4 (DEAD-Box Helicase 4) and PLZF (Promyelocytic Leukaemia Zinc Finger
protein) were chosen as markes for SSCs, both show enrichment for SSC identity and good
antibodies exist for these proteins (Easley et al. 2012). Cells were fixed in 4% paraformaldehyde
(except for the Tra-1 stain) and then blocked for 1 hour at 37°C. Blocking buffer used was 5%
BSA and 5% Normal Goat Serum (NGS), 0.25% Triton-X in PHEM. DDX4 was used in primary
incubation of 1:200, PLZF at 1:50 with secondary antibodies anti-DDX4 (LifeTech Alexafluor
594 goat anti-mouse) at 1:1000 and anti-PLZF (LifeTech alexafluor 488 goat anti-rabbit) at
1:500. Primary incubation was overnight at 4°C, followed by three washes of PHEM with 0.25%
Triton-X of 5 minutes each. Secondary incubation was 2 hours at 37°C followed by three washes
as above. CD9 antibody was conjugated so only a single incubation overnight at 4°C. Hoesch
staining (Sigma) was performed at 37°C for 8 minutes at a concentration of 1:800. Tra-1-81
(Stemgent, StainAlive) was used diluted to 5 μg/mL in SSC media for 30 minutes at 37°C in 5%
CO2 and washed twice with media.
iPSC and SSC colonies were stained with Tra-1-81 (an indicator of pluripotency) and
DDX4 (a marker for spermatogonia), see Figs. 15 and 16. SSC colonies stained for DDX4 but
had lost the pluripotency marker. To further confirm the SSC phenotype, more antibody assays
were done with PLZF, another marker for spermatogonia, and CD9, a marker for stem cells, and
the SSC colonies showed specific binding for all three, see Fig. 17.
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Fig. 15 - Tra-1-81 stains for p
pluripotency.
iPSC and differentiated SSC colonies
c
(iSSC) following 10 days in culture in KSOR and SSC
media respectively, stained
ed with Tra-1-81 without fixing.

Fig. 16 - DDX4 stains forr sper
spermatogonia.
iPSC and differentiated SSC ccolonies were fixed in 4% paramaformaldeh
maldehyde and stained for
hoechst and DDX4.
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Fig. 17 - Staining of differenti
erentiated SSCs for spermatogonial markers
A-F Shown is a SSC colony,
ny, passage
pa
11 after differentiation, 3 weeks post-transfection.
post
A.
Brightfield. B. Hoesch stain
ain for DNA. C. Merge of images A-F. D. Anti-PLZ
PLZF stain, E. AntiDDX4 stain, F. merge of PLZF and DDX4. G-I Shown is a different SSC
SC co
colony. G. Brightfield.
H. Anti-CD9 stain I. Merge
rge of H and I.

5.2.4 Plasmid Design and Tran
Transfection

Plasmids were construc
nstructed as follows: RET9 genes (wt and 2B
B mutant)
mut
supplied as kind
gift by Lois Mulligan (Queen’
ueen’s University, Ontario, Canada) (Gujrall et al
al. 2006). The cDNAs
were supplied within the vector
vecto pcDNA3.1. These were excised by NotI/H
NotI/HindIII digestion and
subsequently blunted, phosph
hosphatased and ligated into SmaI-digested
ed pIRES-hrGFP-1a.
pI
The
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orientation of insert into vector was determined by SacI digestion of recombinant clones. See
Fig. 19.

pCMV
pUC ori
RET9
wt/2b

AmpicillinR
9.2 kb

SV40 pA
hrGFP

IRES

pCMV
AmpicillinR
RET9
wt/2b
pBR322 ori

NeomycinR

9.6 kb

SV40 pA

Fig. 18 - Map of the RET9 plasmids.
A) the pIRES hrGFP 1a RET9 plasmids, one containing the RET9 isoform of the wildtype RET
gene and the other containing the MEN2B T2943C SNP change.
B) the pcDNA3.1 RET9 plasmids, again a pair of plasmids one with the wildtype RET gene and
the other mutant.
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To test the plasmids,
ids, they
th were first transfected into an easy-to-gr
grow cell line. Mouse
fibroblasts (3T3/NIH) were
ere gr
grown under standard cell culture condition
ditions with both wt and
mutant plasmids separately
ely (described
(d
below). See figure 7. A prolifer
roliferative advantage was
confirmed for the mutant-expre
expressing plasmid.

470-bp PCRamplified diagnostic
region (DR) of RET

i) RET wt

BccI

BccI

ii) RET 2B

pIRES
RETwt
DR
BccI

pIRES
RES
RET2b
ET2b
DR
BccI

100bp
ladder

BccI

pIRES
RETwt
DR
uncut

pIRES
RET2b
DR
uncut

pcDNA
RETwt
DR
uncut

pcDNA
RET2b
DR
uncut

100bp
ladder

pcDNA
RETwt
DR
BccI

pcDNA
RET2b
DR
BccI

500 bp

100 bp

Fig. 19 - Diagnostic restriction
riction digest of amplified region of RET.
The T2943C SNP mutation
ion in the RET gene is contained within a BccI
ccI restriction diagnostic
region (DR) amplified byy PCR.
PCR Restriction using the BccI restriction
n endonuclease
endo
cleaves the
wildtype gene at this sequence
uence but not the mutant sequence. (A) diagram
ram of BccI restriction sites
within the SNP-containing
ng amp
amplified region. (B) gel shows the wildtype
type ((wt) amplified region
cleaved whereas the mutant
nt sequence
seq
(2b) is not.

To linearlise the plasmids
plasmi prior to transfection, plasmids weree cut with SSPI restriction
enzyme at 37°C for one hour and
a inactivated at 65°C for 20 minutes. Trans
Transfection was achieved
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with Lipofectamine 3000 (Thermo
(Ther
Fisher Scientific) using 500ng of plasmid
plasm DNA in a 24 well
plate and 1.5μL of P3000 reage
reagent per well. Each sample was split into two hhalves – one received
the wildtype human RET99 cDN
cDNA spliceform and the other received the M918
M
mutant. 4 days
post-transfection, wells were cultured in SSC media supplemented
d with
wit 500mg/ml G4180
Sulfate (Affymetrix) for 3 wee
weeks to ensure only cells with linear integrated
grated geneticin resistance
gene were selected for (IACUC
CUC #12-028).

Cells/ml
45000
40000
35000
30000
25000
20000
15000
10000
5000
0

untransformed

RET wt transformed

RET
T 2b transformed
t

utant on NIH/3T3 cell growth.
Fig. 20 - Effect of RET mutan
Preliminary data using NIH/3T
IH/3T3 cells transformed with pcDNA3.1/RET
RET uunder G418 selection
(200µg/ml). Significant differen
ifference between all three treatment groupss (difference
(diffe
between wt &
2b t-test, p=0.03, n=9). Error bars show standard deviation. Dashed
ed red line shows starting
number before 8 days of growth (untransformed cells died due to G418).
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5.2.5 Cell proliferation assay

Cells were seeded at a density of 10,000 cells/well in a 96-well plate. Cells were supplied
with standard SSC media. Each treatment was seeded in triplicate and every 24 hours, three
wells from each treatment were removed with trypsin and counted using a haemocytometer.

5.3 Results

100000
90000

Cell number

80000
70000
60000
50000
40000
30000
20000
10000
0
Untransformed

WT RET

2B RET

Fig. 21 - cell counts after 4 days of culture of transformed SSCs
Cultured in SSC media with 500 μg/ml G418. Error bars show standard deviation. Significant
difference between all 3 groups (ANOVA, p<0.05)

The SSCs expressing the mutant showed a significant (repeated measures ANOVA,
p<0.05) selective advantage in vitro (see Fig. 23). Both sets of cells grew until cells started to
approach confluence and tapered off but the mutant cells not only grew faster but also appear to
have a higher carrying capacity or tolerance for being at a higher density, which leads to
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speculation that mutant cells may have the capability to exist within the niche in vivo at a higher
density than wildtype cells.

120000

100000

Cells per well

80000

60000

WT
2B

40000

20000

0
1

2

3

4

5

6

Days post seeding

Fig. 22 - Cell growth of mutant and wildtype RET-carrying spermatogonial stem cells
Error bars show standard deviation. Populations show significant difference by day 4 (p<0.05,
repeated measures ANOVA).
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Fig. 23 - Growth of mutant and wildtype tranformed SSCs with varied GDNF
Higher exposure to GDNF promoted faster cell growth to both treatments. The difference
between groups after 4 days of growth was more pronounced with lower GDNF levels. No
significant difference at 100ng/ml, but mutant transfected populations had a significantly higher
number of cells at lower concentrations (t-test, p<0.05).
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5.4 Conclusions
The differentiation procedure transformed iPSCs to SSC-like cells no longer showing
Tra-1-81, but become positive for CD9, PLZF and DDX4, markers consistent with
spermatogonial stem cells. These results need to be treated with some caution: while they show
differentiation into spermatogonia, without a functional assay to confirm stem cell status, there
may be some differences between these cell populations and true spermatogonial stem cells.
Future work will assay additional markers in order to confirm SSC identity. ID4 (Inhibitor of
DNA expression 4) in particular appears to be a very promising marker for SSCs (Sun et al.
2015, Oatley et al. 2011).
This study experimentally confirmed that MEN2B mutations show a selective advantage
for spermatogonia in culture. This effect is most likely due to constitutive downstream activation
of the MAPK pathway (see Fig. 4), and further evidence is provided by the strength of the effect
being dependent on the level of GDNF present (Fig. 23), as the receptor can be saturated by the
ligand.
This chapter shows direct experimental evidence that MEN2B mutations underpin the
strong paternal age effect. This provides mechanistic understanding of the cause of the high
sporadic incidence of this disease and validate the theoretical positive selection model.
In terms of refining this line of inquiry, using the CRISPR/CAS9 gene editing system to
directly edit the RET gene in SSCs would be an improvement as it would be under normal
transcriptional control. Different genes related to other paternal age effect syndromes could be
edited (FGFR2, FGFR3, etc). Moving to an in vivo system in mice would be the next logical step
(discussed more in Chapter 6).
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CHAPTER 6
CONCLUSIONS AND RECOMMENDATIONS

6.1 Conclusions
As we saw in Chapter 2, paternal age can have a modest effect on a range of substitutions
and, over evolutionary time, males represent the source of the majority of substitutions that
occur. However, for strong paternal age effect syndromes, pure copy-error accumulation presents
an inadequate explanation for the observed incidence rates and for the distribution of mutations
observed. This thesis was intended to mathematically model the SSC niche, to understand the
accumulation of mutation and to experimentally show the effect of positive selection in cell
culture.
In Chapter 3 we model normal stem cell homeostasis, which has some interesting
comparisons for spermatogonial stem cell dynamics compared between species. The equations
presented show the conditions required for stem cell homeostasis but allow for the spectrum
between the drosophila germline stem cell system, which has classical asymmetric cell division
that are in constant use and mammalian systems where divisions are likely comprised of
symmetrical divisions with a subsection of cells quiescent. Both systems represent solutions to
the equations that arise from simple initial starting conditions.
In order to incorporate mutation accumulation, we used a Markov chain to model the
probabilities of mutation and positive selection with cell divisions (Chapter 4). The proportions
of mutant to wildtype cells with increasing paternal age was used to generate a simulated
population and observed/expected curves. The parameter for the probability of positive selection
per cell division was estimated by fitting the simulated population model to available data on
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disease incidence (observed/expected) and also the direct mutation estimates to sequencing
assays of sperm donors. Additionally the simulated populations was used to generate a predicted
incidence rates overall of the disorders with given mutation and positive selection values.
Strength of selective advantage is presented for a range of disorders including Apert’s syndrome
and achondroplasia and showed significant agreement between molecular and incidence data.
Incidence of the diseases was predicted closely for most disorders and was heavily influenced by
the site-specific mutation rate caused by hypermutable CpG sites and the number of mutable
alleles. Both positive selection and the rate of copy-error mutations are important in adequately
explaining the paternal age effect. For the two mutations that cause Apert's syndrome the
difference in the incidence rates of the two alleles is accounted for by the mutation rate alone and
both mutations have a similar positive effect. On the other hand, comparison of the mutations in
the Fibroblast Growth Factor Receptor 3 gene that cause achondroplasia and thanatophoric
dysplasia shows a stronger selective advantage for more strongly activating gain-of-function
mutation, as predicted. Overall, the model shows good agreement with existing data on paternal
age effect syndromes. It provides a mathematical understanding of the accumulation of diseasecausing mutations and provides evidence that disorders strongly associated with paternal age are
linked by positive selective advantage.
SSCs were created using induced pluripotent stem cells derived from BJ fibroblasts and
differentiating them with SSC media including the growth factors GDNF, bFGF and GFRa1 over
a period of 10 days. SSC identity compared with the iPSCs was confirmed by
immunohistochemistry with the SSCs staining positive for CD9, PLZF and DDX4 and negative
for the pluripotency marker Tra-1-81. Wildtype and mutant SSCs were generated by transfection
with a pcDNA3.1 plasmid containing the normal RET gene and the gene containing the M918T
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mutation, respectively. Plasmid integration was achieved through treatment with gentamicin and
a restriction-enzyme assay for the mutation was developed. Mutant SSCs showed increased
proliferation in culture. This effect was magnified by decreasing GDNF concentration in culture
and reduced when the GDNF concentration was increased, saturating the receptors. This research
demonstrated experimental evidence for the positive selection effect of the M918T mutation in
RET and validating the hypothesis that this selection effect is to blame for the marked paternal
age effect of multiple endocrine neoplasia 2B. This research is the first direct evidence that
specific gain of function mutations can positively select for stem cells that produce sperm that
carry the devastating disease alleles.

6.2 Implications
The phenomenon of positive selection is one that is a cornerstone of evolution and can be
found throughout nature. For higher organisms, a component of their cells gaining a positive
selective advantage over others must be resisted, for fear of cancer and other deregulated cell
growth. Understanding how deleterious selective mechanisms occur and are counteracted is vital
in understanding human mutational load in somatic and germline tissues.
An observation from the experiment in Chapter 5 is that when the SSCs have unrestricted
growth, there is no significant difference between wildtype and mutant cells. This suggests that
the cells may have less of a response to space limitations and/or antigrowth factors from other
cells. It would be informative to test the growth advantages of the mutant vs wildtype in
circumstances of low and high cell density and also if both populations can be marked with
different fluorescent tags, to coculture together and observe competition between the two groups
of cells directly.
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There are also implications for technologies designed to culture a patient’s cells and then
differentiate them into tissues. In particular, culture of human cells (SSCs and iPSCs) with the
intention of using them to recover spermatogenesis in patients that have undergone gonadotoxic
therapies (Poirot & Schubert 2011) may very well be susceptible to this sort of positive selection
in vitro. As divisions occur in culture, culture flasks may be overtaken by rare mutants. Should

these cells be used to recover spermatogenesis, these mutations would be passed on to offspring.
The implications of this research is important both for understanding the normal
regulation of the stem cell niche, the mechanisms that surround the most extreme cases of
paternally derived genetic disease and the role that delayed reproduction has on the incidence of
de novo inherited disorders.

6.3 Future directions
The model presented in Chapter 2 does not take into accounts the specifics of feedback
mechanisms. A continuation of this work could look specifically at the feedback loops of the
spermatogonial niche and spatial arrangement. A model or simulation of the SSC niche
incorporating the signalling and feedback could be used to confirm the boundary conditions for
homeostasis in Chapter 2.
Future directions will expand the arena of research on this subject to other genes involved
in the same pathways that all share a paternal age effect pattern of disease incidence as well as an
in vivo model involving injecting the plasmids into mouse testes with a marker gene and

observing the kinetics of the stem cells within the normal cell niche.
Electroporation of the whole testis could be used to provide random integration of the
plasmid into a subset of the native SSCs. Alternatively, removal and culture of SSCs from one
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testis could be edited with CRISPR/Cas9 and then marked with a reporter gene and reinjected
into the mouse’s other testis to do lineage tracing of the injected cells. The mathematical
expressions of Chapter 4 could be confirmed with more precise estimation of the positive
selection advantage numerically in vivo.
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APPENDIX A
ADDITIONAL EQUATIONS FOR CHAPTER 3
For t>0, define the function ψ such that

ψ (t ) =

1 − eat
1 − ebt

(61)

where a≠b, b≠0.
Lemma A.1. A necessary and sufficient condition for ψ(t) to be a constant is that a=0.
Proof: First, if a = 0 then (61) guarantees that ψ(t) = 0 for all t > 0.
Conversely, assume ψ(t) to be a constant independent of t. Thus, in particular, ψ(1) =
ψ(2), which amounts to:
1 − ea 1 − e2a
=
1 − eb 1 − e 2 b

(62)

1 − e 2 a 1 − ea 1 + ea
=
.
1 − e 2 b 1 − eb 1 + e b

(63)

1 − ea 1 − e a 1 + ea
.
.
=
1 − eb 1 − eb 1 + eb

(64)

However:

and so

Since b ≠ 0, the above is equivalent to:

1 − ea = (1 − e a ) .

If a ≠ 0 then 1 – ea ≠ 0 and we obtain:

1 + ea
.
1 + eb

(65)
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1=

1 + ea
.
1 + eb

(66)

which implies that a = b, a contradiction. Therefore a = 0, as claimed. This completes the proof
of the lemma.

Lemma A.2 If x and y are finite, then for all ∈ ℝ

e xt − e yt
= te yt .
x→ y x − y

(67)

e xt − e yt
e( x − y )t − 1
= e yt
.
x− y
x− y

(68)

lim
Proof: We write:

and so
 e( x − y )t − 1 
e xt − e yt
= lim  e yt

x→ y x − y
x→ y
x− y 


lim

 e( x − y )t − 1 
= e yt lim 

x→ y
 x− y 
 e zt − 1 
= e yt lim 
 [where z = x − y ]
z →0
 z 
= te yt

as claimed.

.

(69)
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APPENDIX B
SIMULATION OF SPERMATOGONIAL STEM CELL NICHE

This appendix contains supplementary data to Chapter 4.
Source code: C++/R source codes and documentation including compilation instructions are
available under GNU license at https://github.com/anwala/NicheSimulation.

number of cells n,
cell divisions divisions,
experiment runs (or replications) Runs,
probabilities p and r,
mutant cell count mutCount,
m × 1 matrix M (runs matrix), where |M| = Runs,
and m × 1 matrix P (average runs matrix), where |P| = e,
given X ~ U([0,1]), X is a random variable uniformly distributed on [0, 1]
function runNExperiments(divisions, Runs)
for i = 0 to divisions - 1 do
totalRedBallCount = 0;
//this is for a single division instance run multiple independent times
for j = 0 to Runs do
mutCount = Mj;
Mj = nicheSimulation(n, divisions, p, r, mutCount)
totalMutCount = totalMutCount + Mj;
endFor
//average for a single niche over all the runs
Pi = totalMutCount / Runs;
endFor
return P
Supplementary Algorithm B.1: Algorithm for simulation of niche division.
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Supplementary Fig. B.2 Comparison of mathematical model with computer simulation.
Parameters used are arbitrary and intended to test the model. p=5×10-5, r=0.01, n=50, N=105.
Simulation repeated 105 times and mean values reported.
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APPENDIX C
SIMULATION OF APOPTOSIS IN THE SC NICHE
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Supplementary Fig. C.3. Distribution of Apert’s syndrome mutation incidences with age. A.

from Yoon et al. (2009) shows O/E from birth data. B. also from Yoon et al. (2009) shows
mutational assay of sperm. C. shows my simulation.

Fig. C.3 shows comparison of simulation to sequence and birth data. The simulation was
constructed based off the simulations in Appendix B, with the exception that an equal number of
Adark cells were granted to the system as Apale SSCs. Up to age 40 the apoptosis rate is 0, but after
40 the apoptosis rate goes to 0.01 per cell division of Apale SSCs. Upon an apoptotic event, an
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Apale cell is lost (whether mutant or wildtype), then a Adark SSC converts to a wildtype Apale. In
this model Adark cells that convert are not replenished.
While this simulation did match the sequence data from Yoon and colleagues (2009) and
corresponded to their simulation, this result needs to be treated with some scepticism. Firstly, the
evidence that Adark cells operate purely as reserve cells is limited and they may cycle in-and-out
of active division (K Orwig, personal communication, June 2016). Additionally, this model
requires cells to undergo apoptosis starting at age 40 – a continuous low-level apoptosis rate does
not produce this pattern. Finally, if this is the mechanism for this cell replacement, one would
expect this to happen to all paternal age effect syndromes. It’s possible there is a similar “dip” in
other syndromes (see Fig. 12) and sequencing data (Fig 14), there is far from a clear pattern
across all genes, although it may be obscured by stochastic noise or small sample sizes.
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